UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

☑

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED ~~DECEMBER~~JUNE 3130, ~~2024~~2025

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM TO

Commission File No. 001-33861

MOTORCAR PARTS OF AMERICA, INC.

(Exact name of registrant as specified in its charter)

New York		11-2153962
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)
2929 California Street, Torrance, California		90503
(Address of principal executive offices)		(Zip Code)


2929 California Street, Torrance, California		90503
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (310) 212-7910

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01 per share	MPAA	The Nasdaq Global Select Market

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ~~Yes ☑ No ☐~~

Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):


Large accelerated filer ☐	Accelerated filer ☑
Non-accelerated filer ☐	Smaller reporting company ☐
	Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☑

There were 19,~~583~~352,~~711~~135 shares of Common Stock outstanding at ~~February~~August 34, 2025.

MOTORCAR PARTS OF AMERICA, INC.

TABLE OF CONTENTS
PART I — FINANCIAL INFORMATION
	Item 1. Financial Statements		4
		Condensed Consolidated Balance Sheets	4
		Condensed Consolidated Statements of Operations	5
		Condensed Consolidated Statements of Comprehensive Loss	6
		Condensed Consolidated Statements of Shareholders’ Equity	7
		Condensed Consolidated Statements of Cash Flows	8
		Notes to Condensed Consolidated Financial Statements	9
	Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		26
	Item 3. Quantitative and Qualitative Disclosures About Market Risk		36
	Item 4. Controls and Procedures		36
PART II — OTHER INFORMATION
	Item 1. Legal Proceedings		38
	Item 1A. Risk Factors		38
	Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		38
	Item 3. Defaults Upon Senior Securities		38
	Item 5. Other Information		38
	Item 6. Exhibits		39
	SIGNATURES		42

TABLE OF CONTENTS


PART I — FINANCIAL INFORMATION
	Item 1. Financial Statements	4
	Condensed Consolidated Balance Sheets	4
	Condensed Consolidated Statements of Operations	5
	Condensed Consolidated Statements of Comprehensive Income (Loss)	6
	Condensed Consolidated Statements of Shareholders’ Equity	7
	Condensed Consolidated Statements of Cash Flows	8
	Notes to Condensed Consolidated Financial Statements	9
	Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	26
	Item 3. Quantitative and Qualitative Disclosures About Market Risk	34
	Item 4. Controls and Procedures	34
PART II — OTHER INFORMATION
	Item 1. Legal Proceedings	36
	Item 1A. Risk Factors	36
	Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	36
	Item 3. Defaults Upon Senior Securities	36
	Item 5. Other Information	37
	Item 6. Exhibits	38
	SIGNATURES	41

MOTORCAR PARTS OF AMERICA, INC.

GLOSSARY

The following terms are frequently used in the text of this report and have the meanings indicated below.

“Used Core” — An automobile part which has previously been used in the operation of a vehicle. Generally, the Used Core is an original equipment (“OE”) automobile part installed by the vehicle manufacturer and subsequently removed for replacement. Used Cores contain salvageable parts, which are an important raw material in the remanufacturing process. We obtain most Used Cores by providing credits to our customers for Used Cores returned to us under our core exchange programs. Our customers receive these Used Cores from consumers who deliver a Used Core to obtain credit from our customers upon the purchase of a newly remanufactured automobile part. When sufficient Used Cores are not available from our customers, we purchase Used Cores from core brokers, who are in the business of buying and selling Used Cores. The Used Cores purchased from core brokers or returned to us by our customers under the core exchange programs, and which have been physically received by us, are part of our raw material and work-in-process inventory. Used Cores returned by consumers to our customers but not yet returned to us are classified as contract assets until we physically receive these Used Cores.

“Remanufactured Core” — The Used Core underlying an automobile part that has gone through the remanufacturing process and through that process has become part of a newly remanufactured automobile part. The remanufacturing process takes a Used Core, breaks it down into its component parts, replaces those components that cannot be reused and reassembles the salvageable components of the Used Core and additional new components into a remanufactured automobile part. Remanufactured Cores held for sale at our customer locations are included in long-term contract assets. The Remanufactured Core portion of stock adjustment returns are classified as contract assets until we physically receive them.

PART I — FINANCIAL INFORMATION

Item 1. ~~Financial Statements~~

Financial Statements

MOTORCAR PARTS OF AMERICA, INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

		December 31, 2024			March 31, 2024
		June 30, 2025			March 31, 2025
ASSETS		(Unaudited)
Current assets:
Cash and cash equivalents	$	$12,479,000	~~10,810,000~~	$	$9,429,000	~~13,974,000~~
Short-term investments		2,011,000	~~1,909,000~~		1,881,000	~~1,837,000~~
Accounts receivable — net		85,532,000	~~82,040,000~~		91,064,000	~~96,296,000~~
Inventory — net		366,772,000	~~367,028,000~~		359,669,000	~~397,328,000~~
Contract assets		30,329,000	~~22,213,000~~		29,606,000	~~27,139,000~~
Prepaid expenses and other current assets		22,259,000	~~20,304,000~~		19,822,000	~~23,885,000~~
Total current assets		519,382,000	~~504,304,000~~		511,471,000	~~560,459,000~~
Plant and equipment — net		33,194,000	~~30,954,000~~		31,990,000	~~38,338,000~~
Operating lease assets		68,281,000	~~67,552,000~~		66,603,000	~~83,973,000~~
Long-term deferred income taxes		5,504,000	~~5,664,000~~		4,569,000	~~2,976,000~~
Long-term contract assets		340,529,000	~~334,424,000~~		336,268,000	~~320,282,000~~
Goodwill and intangible assets — net		3,693,000	~~3,846,000~~		3,757,000	~~4,274,000~~
Other assets		2,767,000	~~2,764,000~~		2,978,000	~~1,700,000~~
TOTAL ASSETS	$	$973,350,000	~~949,508,000~~	$	$957,636,000	~~1,012,002,000~~
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable and accrued liabilities	$	$176,269,000	~~158,113,000~~	$	$172,117,000	~~185,182,000~~
Customer finished goods returns accrual		32,926,000	~~40,732,000~~		34,411,000	~~38,312,000~~
Contract liabilities		49,396,000	~~36,239,000~~		38,158,000	~~37,591,000~~
Revolving loan		86,856,000	~~94,802,000~~		90,787,000	~~128,000,000~~
Other current liabilities		4,973,000	~~9,417,000~~		5,570,000	~~7,021,000~~
Operating lease liabilities		10,196,000	~~9,308,000~~		9,982,000	~~8,319,000~~
Total current liabilities		360,616,000	~~348,611,000~~		351,025,000	~~404,425,000~~
Convertible notes, related party		40,844,000	~~32,377,000~~		35,207,000	~~30,776,000~~
Long-term contract liabilities		240,021,000	~~231,962,000~~		241,404,000	~~212,068,000~~
Long-term deferred income taxes		488,000	~~524,000~~		362,000	~~511,000~~
Long-term operating lease liabilities		63,056,000	~~66,833,000~~		65,308,000	~~72,240,000~~
Other liabilities		8,212,000	~~6,530,000~~		6,631,000	~~6,872,000~~
Total liabilities		713,237,000	~~686,837,000~~		699,937,000	~~726,892,000~~
Commitments and contingencies
Shareholders' equity:
Preferred stock; par value $.01 per share, 5,000,000 shares authorized; none issued		-	-		-	-
Series A junior participating preferred stock; par value $.01 per share, 20,000 shares authorized; none issued			-			-
Series A junior participating preferred stock; par value $.01 per share,20,000 shares authorized; none issued		-			-
Common stock; par value $.01 per share, 50,000,000 shares authorized; 19,583,711 and 19,662,380 shares issued and outstanding at December 31, 2024 and March 31, 2024, respectively			196,000			197,000
Common stock; par value $.01 per share, 50,000,000 shares authorized;19,352,135 and 19,435,706 shares issued and outstanding at June 30, 2025 and March 31, 2025, respectively		194,000			194,000
Additional paid-in capital		232,897,000	~~236,988,000~~		234,413,000	~~236,255,000~~
Retained earnings		23,075,000	~~20,755,000~~		20,033,000	~~39,503,000~~
Accumulated other comprehensive income		3,947,000	~~4,732,000~~		3,059,000	~~9,155,000~~
Total shareholders' equity		260,113,000	~~262,671,000~~		257,699,000	~~285,110,000~~
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	$973,350,000	~~949,508,000~~	$	$957,636,000	~~1,012,002,000~~

The accompanying notes to condensed consolidated financial statements are an integral part hereof.

MOTORCAR PARTS OF AMERICA, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Operations

(Unaudited)

		Three Months Ended							Nine Months Ended
	Three Months Ended June 30,
		December 31,							December 31,
		2025				2024
		2024				2023			2024			2023
Net sales	$	188,364,000			$	169,887,000
Net sales		$	186,176,000			$	171,862,000		$	564,249,000		$	528,206,000
Cost of goods sold		154,447,000				140,713,000
Cost of goods sold			141,294,000				141,819,000			448,916,000			430,448,000
Gross profit		33,917,000				29,174,000
Gross profit			44,882,000				30,043,000			115,333,000			97,758,000
Operating expenses:
Operating expenses:
General and administrative		12,680,000				16,670,000
General and administrative			16,212,000				15,198,000			47,934,000			42,125,000
Sales and marketing		6,210,000				5,449,000
Sales and marketing			5,621,000				5,931,000			16,904,000			17,038,000
Research and development		3,306,000				2,433,000
Research and development			3,008,000				2,539,000			7,884,000			7,352,000
Foreign exchange impact of lease liabilities and forward contracts		(8,348,000	)			11,078,000
Foreign exchange impact of lease liabilities and forward contracts			2,460,000				(3,149,000	)		18,966,000			(2,659,000	)
Total operating expenses		13,848,000				35,630,000
Total operating expenses			27,301,000				20,519,000			91,688,000			63,856,000
Operating income (loss)		20,069,000				(6,456,000	)
Operating income			17,581,000				9,524,000			23,645,000			33,902,000
Other expenses:
Other expenses:
Interest expense, net		12,812,000				14,387,000
Interest expense, net			14,435,000				18,297,000			43,004,000			45,400,000
Change in fair value of compound net derivative liability		1,790,000				(2,580,000	)
Change in fair value of compound net derivative liability			(260,000	)			1,160,000			(2,460,000	)		1,690,000
Total other expenses		14,602,000				11,807,000
Loss on extinguishment of debt			-				-			-			168,000
Income (loss) before income tax expense (benefit)		5,467,000				(18,263,000	)
Total other expenses			14,175,000				19,457,000			40,544,000			47,258,000
Income tax expense (benefit)		2,425,000				(178,000	)
Income (loss) before income tax expense			3,406,000				(9,933,000	)		(16,899,000	)		(13,356,000	)
Net income (loss)	$	3,042,000			$	(18,085,000	)
Income tax expense			1,115,000				37,281,000			1,849,000			37,226,000
Basic net income (loss) per share	$	0.16			$	(0.92	)
Net income (loss)		$	2,291,000			$	(47,214,000	)	$	(18,748,000	)	$	(50,582,000	)
Diluted net income (loss) per share	$	0.15			$	(0.92	)
Basic net income (loss) per share		$	0.12			$	(2.40	)	$	(0.95	)	$	(2.58	)
Weighted average number of shares outstanding:
Diluted net income (loss) per share		$	0.11			$	(2.40	)	$	(0.95	)	$	(2.58	)
Basic		19,369,060				19,674,539
Weighted average number of shares outstanding:
Diluted		19,917,663				19,674,539
Basic			19,783,170				19,634,306			19,739,481			19,580,960
Diluted			20,416,958				19,634,306			19,739,481			19,580,960

The accompanying notes to condensed consolidated financial statements are an integral part hereof.

MOTORCAR PARTS OF AMERICA, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Comprehensive Income (Loss)

(Unaudited)

		Three Months Ended							Nine Months Ended
		Three Months EndedJune 30,
		December 31,							December 31,
		2025				2024
		2024				2023			2024			2023
Net income (loss)	$	3,042,000			$	(18,085,000	)
Net income (loss)		$	2,291,000			$	(47,214,000	)	$	(18,748,000	)	$	(50,582,000	)
Other comprehensive income (loss), net of tax:
Other comprehensive (loss) income, net of tax:
Foreign currency translation gain (loss)		888,000				(675,000	)
Foreign currency translation (loss) gain			(2,480,000	)			2,405,000			(4,423,000	)		7,870,000
Total other comprehensive income (loss), net of tax		888,000				(675,000	)
Total other comprehensive (loss) income, net of tax			(2,480,000	)			2,405,000			(4,423,000	)		7,870,000
Comprehensive income (loss)	$	3,930,000			$	(18,760,000	)
Comprehensive loss		$	(189,000	)		$	(44,809,000	)	$	(23,171,000	)	$	(42,712,000	)

The accompanying notes to condensed consolidated financial statements are an integral part hereof.

MOTORCAR PARTS OF AMERICA, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Shareholders’ Equity

(Unaudited)

	Common Stock	~~Common Stock~~
		Shares				Amount				~~AdditionalPaid~~Additional Paid-~~inCapital~~in Capital				~~RetainedEarnings~~Retained Earnings				~~AccumulatedOtherComprehensiveIncome~~Accumulated Other Comprehensive Income (Loss)				Total
Balance at March 31, 2024			19,662,380			$	197,000			$	236,255,000			$	39,503,000			$	9,155,000			$	285,110,000
Balance at March 31, 2025		19,435,706			$	194,000			$	234,413,000			$	20,033,000			$	3,059,000			$	257,699,000
Compensation recognized under employee stock plans			-				-				1,000,000				-				-				1,000,000
Share-based compensation expense		-				-				946,000				-				-				946,000
Issuance of common stock upon vesting of RSUs, net of shares withheld for employee taxes			91,205				1,000				(182,000	)			-				-				(181,000	)
Issuance of common stock upon vesting of RSUs and PSUs, net of shares withheld for employee taxes		114,225				2,000				(498,000	)			-				-				(496,000	)
Foreign currency translation			-				-				-				-				(675,000	)			(675,000	)
Repurchase and cancellation of common stock, including fees		(197,796	)			(2,000	)			(1,964,000	)			-				-				(1,966,000	)
Net loss			-				-				-				(18,085,000	)			-				(18,085,000	)
Foreign currency translation		-				-				-				-				888,000				888000
Balance at June 30, 2024			19,753,585			$	198,000			$	237,073,000			$	21,418,000			$	8,480,000			$	267,169,000
Net income		-				-				-				3,042,000				-				3,042,000
Compensation recognized under employee stock plans			-				-				1,016,000				-				-				1,016,000
Balance at June 30, 2025		19,352,135			$	194,000			$	232,897,000			$	23,075,000			$	3,947,000			$	260,113,000
Issuance of common stock upon vesting of RSUs, net of shares withheld for employee taxes			22,788				-				-				-				-				-
Foreign currency translation			-				-				-				-				(1,268,000	)			(1,268,000	)
Net loss			-				-				-				(2,954,000	)			-				(2,954,000	)
Balance at September 30, 2024			19,776,373			$	198,000			$	238,089,000			$	18,464,000			$	7,212,000			$	263,963,000
Compensation recognized under employee stock plans			-				-				993,000				-				-				993,000
Issuance of common stock upon vesting of RSUs, net of shares withheld for employee taxes			75,468				1,000				(1,000	)			-				-				-
Repurchase and cancellation of common shares			(268,130	)			(3,000	)			(2,093,000	)			-				-				(2,096,000	)
Foreign currency translation			-				-				-				-				(2,480,000	)			(2,480,000	)
Net income			-				-				-				2,291,000				-				2,291,000
Balance at December 31, 2024			19,583,711			$	196,000			$	236,988,000			$	20,755,000			$	4,732,000			$	262,671,000

	Common Stock	~~Common Stock~~
		Shares			Amount			Additional Paid-in Capital				Retained Earnings				Accumulated Other Comprehensive Income (Loss)				Total
Balance at March 31, 2023			19,494,615		$	195,000		$	231,836,000			$	88,747,000			$	(303,000	)		$	320,475,000
Balance at March 31, 2024		19,662,380		$	197,000		$	236,255,000			$	39,503,000			$	9,155,000			$	285,110,000
Compensation recognized under employee stock plans			-			-			1,310,000				-				-				1,310,000
Share-based compensation expense		-			-			1,000,000				-				-				1,000,000
Issuance of common stock upon vesting of RSUs,net of shares withheld for employee taxes			104,530			1,000			(280,000	)			-				-				(279,000	)
Issuance of common stock upon vesting of RSUs and PSUs, net of shares withheld for employee taxes		91,205			1,000			(182,000	)			-				-				(181,000	)
Foreign currency translation		-	-		-	-		-	-			-	-			(675,000	~~3,343,000~~)			(675,000	~~3,343,000~~)
Net loss		-	-		-	-		-	-			(18,085,000	~~(1,410,000~~)	)		-	-			(18,085,000	~~(1,410,000~~)	)
Balance at June 30, 2023			19,599,145		$	196,000		$	232,866,000			$	87,337,000			$	3,040,000			$	323,439,000
Balance at June 30, 2024		19,753,585		$	198,000		$	237,073,000			$	21,418,000			$	8,480,000			$	267,169,000
Compensation recognized under employee stock plans			-			-			1,533,000				-				-				1,533,000
Issuance of common stock upon vesting of RSUs,net of shares withheld for employee taxes			50			-			-				-				-				-
Foreign currency translation			-			-			-				-				2,122,000				2,122,000
Net loss			-			-			-				(1,958,000	)			-				(1,958,000	)
Balance at September 30, 2023			19,599,195		$	196,000		$	234,399,000			$	85,379,000			$	5,162,000			$	325,136,000
Compensation recognized under employee stock plans			-			-			1,425,000				-				-				1,425,000
Issuance of common stock upon vesting of RSUs, net of shares withheld for employee taxes			63,185			1,000			(1,000	)			-				-				-
Foreign currency translation			-			-			-				-				2,405,000				2,405,000
Net loss			-			-			-				(47,214,000	)			-				(47,214,000	)
Balance at December 31, 2023			19,662,380		$	197,000		$	235,823,000			$	38,165,000			$	7,567,000			$	281,752,000

The accompanying notes to condensed consolidated financial statements are an integral part hereof.

MOTORCAR PARTS OF AMERICA, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(Unaudited)

		Nine Months Ended
	Three Months Ended
		December 31,
	June 30,
		2024				2023
		2025				2024
Cash flows from operating activities:
Net loss		$	(18,748,000	)		$	(50,582,000	)
Net income (loss)	$	3,042,000			$	(18,085,000	)
Adjustments to reconcile net loss to net cash provided by operating activities:
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization		2,449,000	~~7,862,000~~			2,729,000	~~8,844,000~~
Amortization of debt issuance costs		590,000	~~1,647,000~~			537,000	~~1,809,000~~
Amortization of interest on contract liabilities		162,000	~~578,000~~			203,000	~~719,000~~
Accrued interest on convertible notes, related party		968,000	~~2,640,000~~			880,000	~~2,400,000~~
Amortization of core premiums paid to customers		2,621,000	~~7,310,000~~			2,471,000	~~7,627,000~~
Amortization of finished goods premiums paid to customers		226,000	~~703,000~~			257,000	~~575,000~~
Noncash lease expense		2,435,000	~~7,265,000~~			2,608,000	~~7,614,000~~
Foreign exchange impact of lease liabilities and forward contracts		(8,348,000	~~18,966,000~~)			11,078,000	~~(2,659,000~~	)
Change in fair value of compound net derivative liability		1,790,000	~~(2,460,000~~	)		(2,580,000	~~1,690,000~~)
Gain on short-term investments		(131,000	~~(126,000~~)	)		(28,000	~~(237,000~~)	)
Net provision for inventory reserves		2,084,000	~~11,317,000~~			3,184,000	~~9,637,000~~
Net provision for customer payment discrepancies and credit losses		401,000	~~324,000~~			34,000	~~1,112,000~~
Deferred income taxes		(339,000	~~(3,479,000~~)	)		(1,862,000	~~29,721,000~~)
Share-based compensation expense		946,000	~~3,009,000~~			1,000,000	~~4,268,000~~
(Gain) loss on disposal of plant and equipment			(6,000	)			9,000
Loss on disposal of plant and equipment		17,000				-
Changes in operating assets and liabilities:
Accounts receivable		5,994,000	~~12,475,000~~			17,207,000	~~26,272,000~~
Inventory		(8,046,000	~~17,546,000~~)			(9,061,000	~~(46,558,000~~)	)
Prepaid expenses and other current assets		725,000	~~(1,000,000~~	)		(1,232,000	~~5,316,000~~)
Other assets		394,000	~~(1,392,000~~	)		(785,000	~~(392,000~~)	)
Accounts payable and accrued liabilities		4,013,000	~~(22,854,000~~	)		(20,367,000	~~38,734,000~~)
Customer finished goods returns accrual		(1,551,000	~~2,637,000~~)			(9,275,000	~~(190,000~~)	)
Contract assets		(7,499,000	~~(18,031,000~~)	)		1,482,000	~~(7,639,000~~	)
Contract liabilities		9,359,000	~~18,300,000~~			2,089,000	~~15,561,000~~
Operating lease liabilities		(2,484,000	~~(6,754,000~~)	)		(2,162,000	~~(6,368,000~~)	)
Other liabilities		210,000	~~(1,361,000~~	)		(1,163,000	~~1,162,000~~)
Net cash provided by operating activities			36,368,000				48,445,000
Net cash provided by (used in) operating activities		10,028,000				(20,841,000	)
Cash flows from investing activities:
Purchase of plant and equipment		(807,000	~~(1,716,000~~)	)		(490,000	~~(462,000~~)	)
Proceeds for the sale of plant and equipment			49,000				-
Redemption of short-term investments		1,000				(22,000	)
Redemption of short-term investments			53,000				42,000
Net cash used in investing activities		(806,000	)			(512,000	)
Net cash used in investing activities			(1,614,000	)			(420,000	)
Cash flows from financing activities:
Cash flows from financing activities:
Borrowings under revolving loan		188,676,000				42,366,000
Borrowings under revolving loan			375,461,000				64,005,000
Repayments of revolving loan		(192,607,000	)			(26,532,000	)
Repayments of revolving loan			(408,659,000	)			(94,205,000	)
Payments for debt issuance costs		-				(15,000	)
Repayments of term loan			-				(13,125,000	)
Payments on finance lease obligations		(385,000	)			(472,000	)
Payments for debt issuance costs			(15,000	)			(2,617,000	)
Cash used to net share settle equity awards		(496,000	)			(181,000	)
Payments on finance lease obligations			(1,306,000	)			(1,425,000	)
Repurchase of common stock, including fees		(1,966,000	)			-
Cash used to net share settle equity awards			(181,000	)			(279,000	)
Net cash (used in) provided by financing activities		(6,778,000	)			15,166,000
Repurchase of common stock			(2,096,000	)			-
Effect of exchange rate changes on cash and cash equivalents		606,000				(256,000	)
Net cash used in financing activities			(36,796,000	)			(47,646,000	)
Net increase (decrease) in cash and cash equivalents		3,050,000				(6,443,000	)
Effect of exchange rate changes on cash and cash equivalents			(1,122,000	)			180,000
Cash and cash equivalents — Beginning of period		9,429,000				13,974,000
Net (decrease) increase in cash and cash equivalents			(3,164,000	)			559,000
Cash and cash equivalents — End of period	$	12,479,000			$	7,531,000
Cash and cash equivalents — Beginning of period			13,974,000				11,596,000
Supplemental disclosures of cash flow information:
Cash and cash equivalents — End of period		$	10,810,000			$	12,155,000
Cash paid for interest, net	$	11,154,000			$	12,689,000
Supplemental disclosures of cash flow information:
Cash paid for income taxes, net of refunds		550,000				2,196,000
Cash paid for interest, net		$	37,845,000			$	40,826,000
Cash paid for operating leases		3,688,000				3,355,000
Cash paid for income taxes, net of refunds			4,338,000				8,143,000
Cash paid for finance leases		459,000				523,000
Cash paid for operating leases			10,183,000				10,025,000
Plant and equipment acquired under finance leases		1,788,000				-
Cash paid for finance leases			1,446,000				1,595,000
Assets acquired under operating leases		198,000				1,815,000
Plant and equipment acquired under finance leases			684,000				33,000
Non-cash capital expenditures		192,000				19,000
Assets acquired under operating leases			2,512,000				879,000
Non-cash capital expenditures			144,000				71,000
Debt issuance costs included in accounts payable and accrued liabilities			-				1,340,000

The accompanying notes to condensed consolidated financial statements are an integral part hereof.

MOTORCAR PARTS OF AMERICA, INC. AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

~~December~~June 3130, ~~2024~~2025

(Unaudited)

1. Company Background and Organization

Motorcar Parts of America, Inc. and its subsidiaries (the “Company”, or “MPA”) is a leading supplier of automotive aftermarket non-discretionary replacement parts, and test solutions and diagnostic equipment. These replacement parts are primarily sold to automotive retail chain stores and warehouse distributors throughout North America and to major automobile manufacturers for both their aftermarket programs and warranty replacement programs (“OES”). The Company’s test solutions and diagnostic equipment primarily serves the global automotive component and powertrain testing market. The Company’s products include (i) light duty and heavy duty rotating electrical products such as alternators and starters, (ii) wheel hub assemblies and bearings, (iii) brake-related products, which include brake calipers, brake boosters, brake rotors, brake pads, ~~brake shoes,~~ and brake master cylinders, and (iv) other products, which include (a) turbochargers and (b) test solutions and diagnostic equipment including: (i) applications for combustion engine vehicles, including bench -top testers for alternators and starters, (ii) equipment for the pre- and post-production of electric vehicles, and (iii) software emulation of power system applications for the electrification of all forms of transportation (including automobiles, trucks, the emerging electrification of systems within the aerospace industry, and electric vehicle charging stations).

2. Basis of Presentation and New Accounting Pronouncements

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three ~~and nine~~ months ended ~~December~~June 3130, ~~2024~~2025 are not necessarily indicative of the results that may be expected for the fiscal year ending March 31, ~~2025~~2026. This report should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto for the fiscal year ended March 31, ~~2024~~2025, which are included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on June 119, ~~2024, and the 10-K/A for the fiscal year ended March 31, 2024 as filed with the SEC on June 28, 2024~~2025.

The accompanying condensed consolidated financial statements have been prepared on a consistent basis with, and there have been no material changes to the accounting policies described in Note 2, Summary of Significant Accounting Policies, to the consolidated financial statements that are presented in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, ~~2024~~2025.

Accounting Pronouncements Not Yet Adopted

Disclosure Improvements

In October 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2023-06, Disclosure Improvements: Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative. This standard was issued in response to the SEC’s disclosure update and simplification initiative, which affects a variety of topics within the Accounting Standards Codification. The amendments apply to all reporting entities within the scope of the affected topics unless otherwise indicated. The effective date for each amendment will be the date on which the SEC’s removal of that related disclosure from Regulation S-X or Regulation S-K becomes effective, with early adoption prohibited. The Company is currently evaluating the impact this guidance will have on its financial statement disclosures.

Reportable Segment Disclosures

In November 2023, the FASB issued ASU 2023-07, Improvements to Reportable Segment Disclosures (Topic 280). This standard requires the Company to disclose significant segment expenses that are regularly provided to the CODM and are included within each reported measure of segment operating results. The standard also requires the Company to disclose the total amount of any other items included in segment operating results, which were not deemed to be significant expenses for separate disclosure, along with a qualitative description of the composition of these other items. In addition, the standard also requires disclosure of the CODM’s title and position, as well as detail on how the CODM uses the reported measure of segment operating results to evaluate segment performance and allocate resources. The standard also aligns interim segment reporting disclosure requirements with annual segment reporting disclosure requirements. This guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact this guidance will have on its financial statement disclosures.

Improvements to Income Tax Disclosures

In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures (Topic 740). This standard requires the Company to provide further disaggregated income tax disclosures for specific categories on the effective tax rate reconciliation, as well as additional information about federal, state/local and foreign income taxes. The standard also requires the Company to annually disclose its income taxes paid (net of refunds received), disaggregated by jurisdiction. This guidance is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The standard is to be applied prospective basis, although optional retrospective application is permitted. The Company is currently evaluating the impact this guidance will have on its financial statement disclosures.

Disaggregation of Income Statement Expenses

In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses (“DISE”) (Subtopic 220-40). This standard requires the Company to disclose, in the footnotes at each interim and annual reporting period, information about expenses by the nature of the expense in addition to certain disclosures about selling expenses. Entities are required to include the following relevant expense captions: (i) purchase of inventory, (ii) employee compensation, (iii) depreciation, (iv) intangible asset amortization, and (v) depreciation, depletion and amortization recognized as part of oil and gas producing activities. ~~This~~In January 2025, the FASB issued ASU No. 2025-01, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40) Clarifying the Effective Date, which is intended to clarify the effective date of ASU No. 2024-03. As clarified in ASU 2025-01, the new guidance is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027, ~~on a prospective basis~~ with ~~the~~early ~~option for retrospective application. Early~~ adoption is permitted. The Company is currently evaluating the impact this guidance will have on its financial statement disclosures.

Debt with Conversion and Other Options

In November 2024, the FASB issued ASU 2024-04, Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments, which seeks to clarify the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as an induced conversion. This guidance is effective for annual periods beginning after December 15, 2025, including interim periods within those fiscal years., ~~Early~~with early adoption is permitted. The Company is currently evaluating the impact this guidance will have on its financial statement disclosures.

3. Accounts Receivable — Net

The Company has trade accounts receivable that result from the sale of goods and services. Accounts receivable — net includes offset accounts related to allowances for credit losses, customer payment discrepancies, and returned goods authorizations (“RGAs”) issued for in-transit unit returns. The Company uses accounts receivable discount programs with certain customers and their respective banks (see Note 10).

Accounts receivable — net is comprised of the following:


		June 30, 2025			March 31, 2025
Accounts receivable - net
Accounts receivable — trade	$	109,041,000		$	113,807,000
Allowance for credit losses		(264,000	)		(207,000	)
Customer payment discrepancies		(2,015,000	)		(1,765,000	)
Customer returns RGA issued		(21,230,000	)		(20,771,000	)
Total accounts receivable — net	$	85,532,000		$	91,064,000

Accounts receivable — net is comprised of the following:

	December 31, 2024			March 31, 2024
Accounts receivable — trade	$	95,653,000		$	118,500,000
Allowance for credit losses		(77,000	)		(189,000	)
Customer payment discrepancies		(1,706,000	)		(1,206,000	)
Customer returns RGA issued		(11,830,000	)		(20,809,000	)
Total accounts receivable — net	$	82,040,000		$	96,296,000

4. Inventory — Net

Inventory — net is comprised of the following:

		December 31, 2024				March 31, 2024
		June 30, 2025				March 31, 2025
Inventory — net
Raw materials	$	$154,325,000	~~157,397,000~~		$	$150,274,000	~~158,819,000~~
Work-in-process		8,917,000	~~9,750,000~~			7,821,000	~~7,943,000~~
Finished goods		204,604,000	~~201,049,000~~			202,078,000	~~227,650,000~~
			368,196,000				394,412,000
		367,846,000				360,173,000
Less allowance for excess and obsolete inventory		(19,566,000	~~(18,538,000~~)	)		(18,964,000	~~(17,372,000~~)	)
Inventory		348,280,000	~~349,658,000~~			341,209,000	~~377,040,000~~
Inventory unreturned		18,492,000	~~17,370,000~~			18,460,000	~~20,288,000~~
Total inventory — net	$	$366,772,000	~~367,028,000~~		$	$359,669,000	~~397,328,000~~

5. Contract Assets

During the three months ended ~~December~~June 3130, ~~2024~~2025 and ~~2023~~2024, the Company reduced the carrying value of Remanufactured Cores held at customers’ locations by $~~758,000 and $~~1,~~607~~026,000, ~~respectively. During the nine months ended December 31, 2024~~ and ~~2023, the Company reduced the carrying value of Remanufactured Cores held at customers’ locations by~~ $2394,~~316,~~000 ~~and $4~~,~~380,000,~~ respectively.

Contract assets are comprised of the following:

		December 31, 2024			March 31, 2024
		June 30, 2025			March 31, 2025
Short-term contract assets
Cores expected to be returned by customers	$	$18,151,000	~~10,567,000~~	$	$17,732,000	~~15,409,000~~
Core premiums paid to customers		9,981,000	~~9,454,000~~		9,669,000	~~9,567,000~~
Upfront payments to customers		1,350,000	~~1,450,000~~		1,400,000	~~1,407,000~~
Finished goods premiums paid to customers		847,000	~~742,000~~		805,000	~~756,000~~
Total short-term contract assets	$	$30,329,000	~~22,213,000~~	$	$29,606,000	~~27,139,000~~
Remanufactured cores held at customers' locations		$	300,166,000		$	279,427,000
Long-term contract assets
Core premiums paid to customers			24,771,000			30,227,000
Remanufactured cores held at customers' locations	$	305,398,000		$	301,388,000
Long-term core inventory deposits			5,569,000			5,569,000
Core premiums paid to customers		25,131,000			24,714,000
Finished goods premiums paid to customers			2,138,000			2,341,000
Long-term core inventory deposits		5,569,000			5,569,000
Upfront payments to customers			1,780,000			2,718,000
Finished goods premiums paid to customers		2,627,000			2,483,000
Total long-term contract assets		$	334,424,000		$	320,282,000
Upfront payments to customers		1,804,000			2,114,000
Total long-term contract assets	$	340,529,000		$	336,268,000

6. Significant Customer and Other Information

Significant Customer Concentrations

The largest customers accounted for the following percentage of consolidated net sales:

		Three Months Ended						Nine Months Ended
	Three Months Ended June 30,
		December 31,						December 31,
		2025			2024
		2024			2023			2024			2023
Net sales
Net sales
Customer A		39	%		40	%
Customer A			41	%		34	%		38	%		35	%
Customer B		24	%		17	%
Customer C		22	23%	%	28	26%	%		27	%		27	%
Customer B			22	%		23	%		20	%		21	%

Revenues for these customers were derived from the Hard Parts segment and Test Solutions and Diagnostic Equipment segment. See Note 18 for a discussion of the Company’s segments.

The largest customers accounted for the following percentage of accounts receivable – trade:

	December 31, 2024			March 31, 2024
	June 30, 2025			March 31, 2025
Accounts receivable - trade
Customer A	48	48%	%	41	35%	%
Customer C		2	%		13	%
Customer B	23	%		26	%
Customer B		20	%		25	%
Customer C	-	%		7	%

Geographic and Product Information

The Company’s products are sold predominantly in North America and accounted for the following percentages of consolidated net sales:

		Three Months Ended						Nine Months Ended
	Three Months Ended June 30,
		December 31,						December 31,
		2025			2024
		2024			2023			2024			2023
Product line
Product line
Rotating electrical products		66	%		65	%
Rotating electrical products			68	%		65	%		67	%		66	%
Brake-related products		23	%		24	%
Brake-related products			21	%		21	%		22	%		21	%
Wheel hub products		6	%		7	%
Wheel hub products			8	%		11	%		7	%		10	%
Other products		5	%		4	%
Other products			3	%		3	%		4	%		3	%
		100	%		100	%
			100	%		100	%		100	%		100	%

Significant Supplier Concentrations

The Company had no suppliers that accounted for more than 10% of inventory purchases for the three ~~and nine~~ months ended ~~December~~June 3130, ~~2024~~2025 and ~~2023~~2024.

7. Debt

The Company has $268,620,000 in senior secured financing, (as amended from time to time, the “Credit Facility”) consisting of a $238,620,000 revolving loan facility (the “Revolving Facility”), subject to certain restrictions, and a $30,000,000 term loan facility (the “Term Loans”). The Term Loans were repaid during the year ended March 31, 2024. The Credit Facility matures on December 12, 2028. The lenders have a security interest in substantially all of the assets of the Company. In June 2024, the Company enrolled in a feature with its lenders, under which the Company sweeps its cash collections to pay down its revolving facility and borrows on-demand to fund payments. This feature is expected to reduce interest expense on borrowings under the Credit Facility.

The Company had $9486,~~802~~856,000 and $~~128~~90,~~000~~787,000 outstanding under the Revolving Facility at ~~December~~June 3130, ~~2024~~2025 and March 31, ~~2024~~2025, respectively. In addition, $711,~~047~~888,000 was outstanding for letters of credit at ~~December~~June 3130, ~~2024~~2025. At ~~December~~June 3130, ~~2024~~2025, after certain contractual adjustments, $~~127~~134,~~962~~341,000 was available under the Revolving Facility. The interest rate on the Company’s Revolving Facility was 7.6640% and 87.4346%, at ~~December~~June 3130, ~~2024~~2025 and March 31, ~~2024~~2025, respectively.

The Credit Facility requires the Company to maintain a minimum fixed charge coverage ratio if undrawn availability is less than 22.5% of the aggregate revolving commitments and a specified minimum undrawn availability. During the ~~nine~~three months ended ~~December~~June 3130, ~~2024~~2025, undrawn availability was greater than the 22.5% threshold, therefore, the fixed charge coverage ratio financial covenant was not required to be tested.

Convertible Notes

On March 31, 2023, the Company entered into a note purchase agreement, as amended, (the “Note Purchase Agreement”) with Bison Capital Partners VI, L.P. and Bison Capital Partners VI-A, L.P. (collectively, the “Purchasers”) and Bison Capital Partners VI, L.P., as the purchaser representative (the “Purchaser Representative”) for the issuance and sale of $32,000,000 in aggregate principal amount of convertible notes due in 2029 (the “Convertible Notes”), which was used for general corporate purposes. The Convertible Notes bear interest at a rate of 10.0% per annum, compounded annually, and payable (i) in-kind or (ii) in cash, annually in arrears on April 1 of each year, commencing on April 1, 2024. In April ~~2024~~2025, non-cash accrued interest on the Convertible Notes of $3,~~209~~521,000 was paid in-kind and is included in the principal amount of Convertible Notes at ~~December~~June 3130, ~~2024~~2025. The Convertible Notes have an initial conversion price of $15.00 per share of the Company's common stock, subject to adjustment as provided in the Convertible Notes (“Conversion Option”). Unless and until the Company delivers a redemption notice, the Purchasers of the Convertible Notes may convert their Convertible Notes at any time at their option. Upon conversion, the Convertible Notes will be settled in shares of the Company’s common stock. Except in the case of the occurrence of a fundamental transaction, as defined in the form of convertible promissory note, the Company may not redeem the Convertible Notes prior to March 31, 2026. After March 31, 2026, the Company may redeem all or part of the Convertible Notes for a cash purchase (the “Company Redemption”) price. The effective interest rate was 18.3% as of ~~December~~June 3130, ~~2024~~2025 and March 31, ~~2024~~2025, respectively.

The Company’s Convertible Notes are comprised of the following:

		December 31, 2024				March 31, 2024
		June 30, 2025				March 31, 2025
Principal amount of Convertible Notes		$	35,209,000			$	32,000,000
Convertible Notes, related party
Less: unamortized debt discount attributed to Compound Net Derivative Liability			(6,829,000	)			(7,576,000	)
Principal amount of Convertible Notes	$	38,730,000			$	35,209,000
Less: unamortized debt discount attributed to debt issuance costs			(953,000	)			(1,058,000	)
Less: unamortized debt discount attributed to Compound Net Derivative Liability		(6,271,000	)			(6,556,000	)
Carrying amount of the Convertible Notes			27,427,000				23,366,000
Less: unamortized debt discount attributed to debt issuance costs		(875,000	)			(916,000	)
Plus: Compound Net Derivative Liability			4,950,000				7,410,000
Carrying amount of the Convertible Notes		31,584,000				27,737,000
Net carrying amount of Convertible Notes, related party		$	32,377,000			$	30,776,000
Plus: Compound Net Derivative Liability		9,260,000				7,470,000
Net carrying amount of Convertible Notes, related party	$	40,844,000			$	35,207,000

In connection with the Note Purchase Agreement, the Company entered into common stock warrants (the “Warrants”) with the Purchasers, which mature on March 30, 2029. The fair value of the Warrants, using Level 3 inputs and the Monte Carlo simulation model, was zero at ~~December~~June 3130, ~~2024~~2025 and March 31, ~~2024~~2025.

The Company Redemption option has been combined with the Conversion Option as a compound net derivative liability (the “Compound Net Derivative Liability”). The Compound Net Derivative Liability has been recorded within convertible note, related party in the condensed consolidated balance sheets at ~~December~~June 3130, ~~2024~~2025 and March 31, ~~2024~~2025. The fair value of the Conversion Option and the Company Redemption option using Level 3 inputs and the Monte Carlo simulation model was a liability of $512,~~600~~900,000 and $9,~~800~~000,000, and an asset of $~~650~~3,640,000 and $21,~~390~~530,000 at ~~December~~June 3130, ~~2024~~2025 and March 31, ~~2024~~2025, respectively. During the three months ended ~~December~~June 3130, ~~2024~~2025 and ~~2023~~2024, the Company recorded a ~~gain of $260,000 and a~~ loss of $1,~~160~~790,000, ~~respectively, as the change in fair value of the Compound Net Derivative Liability in the condensed consolidated statements of operations. During the nine months ended December 31, 2024~~ and ~~2023, the Company recorded~~ a gain of $2,~~460~~580,000 ~~and a loss of $1~~,~~690,000,~~ respectively, as the change in fair value of the Compound Net Derivative Liability in the condensed consolidated statements of operations and condensed consolidated statements of cash flows.

The Convertible Notes also contain additional features, such as, default interest and options related to a fundamental transaction, which were not separately accounted for as the value of such features were not material at ~~December~~June 3130, ~~2024~~2025 and March 31, ~~2024~~2025.

Interest expense related to the Convertible Notes is as follows:

		Three Months Ended					Nine Months Ended
		Three Months EndedJune 30,
		December 31,					December 31,
		2025			2024
		2024			2023		2024		2023
Interest expense on Convertible Notes
Contractual interest expense	$	$968,000	~~880,000~~	$	$880,000	~~800,000~~	$	~~2,640,000~~	$	~~2,400,000~~
Accretion of debt discount		285,000	~~260,000~~		238,000	~~217,000~~		~~747,000~~		~~626,000~~
Amortization of debt issuance costs		41,000	~~37,000~~		33,000	~~30,000~~		~~105,000~~		~~87,000~~
Total interest expense		$	1,177,000		$	1,047,000	$	3,492,000	$	3,113,000
Total interest expense on Convertible Notes	$	1,294,000		$	1,151,000

There are no future payments required under the Convertible Notes prior to their maturity, therefore, the principal amount of the Convertible Notes plus interest payable in-kind, assuming no early redemption or conversion has occurred, of $56,704,000 would be paid on March 30, 2029.

8. Contract Liabilities

Contract liabilities are comprised of the following:

		December 31, 2024			March 31, 2024
		June 30, 2025			March 31, 2025
Short-term contract liabilities
Customer allowances earned	$	$17,814,000	~~19,472,000~~	$	$16,283,000	~~19,789,000~~
Customer core returns accruals		14,826,000	~~9,081,000~~		13,880,000	~~10,448,000~~
Accrued core payment			3,144,000			3,476,000
Core bank liability		11,399,000			1,795,000
Customer deposits			2,257,000			1,735,000
Accrued core payment		3,117,000			3,196,000
Core bank liability			1,780,000			1,739,000
Customer deposits		2,137,000			2,486,000
Finished goods liabilities		103,000	~~505,000~~		518,000	~~404,000~~
Total short-term contract liabilities	$	$49,396,000	~~36,239,000~~	$	$38,158,000	~~37,591,000~~
Long-term contract liabilities
Customer core returns accruals	$	$236,875,000	~~216,779,000~~	$	$227,588,000	~~193,545,000~~
Core bank liability			10,502,000			11,843,000
Accrued core payment		3,146,000			3,768,000
Accrued core payment			4,681,000			6,535,000
Core bank liability		-			10,048,000
Finished goods liabilities			-			145,000
Total long-term contract liabilities	$	240,021,000		$	241,404,000
Total long-term contract liabilities		$	231,962,000		$	212,068,000

9. Leases

The Company leases various facilities in North America and Asia under operating leases expiring through August 2033. The Company has material nonfunctional currency leases that could have a material impact on the Company’s condensed consolidated statements of operations. As required for other monetary liabilities, lessees remeasure foreign currency-denominated lease liabilities using the exchange rate at each reporting date, but the lease assets are nonmonetary assets measured at historical rates and are not affected by subsequent changes in the exchange rates. In connection with the remeasurement of these leases, the Company recorded a ~~loss of $1,875,000 and a~~ gain of $24,~~608~~002,000 ~~during the three months ended December 31, 2024~~ and ~~2023, respectively. In connection with the remeasurement of these leases, the Company recorded~~ a loss of $115,~~562~~709,000 ~~and a gain of $4,430,000~~ during the ~~nine~~three months ended ~~December~~June 3130, ~~2024~~2025 and ~~2023~~2024, respectively. These amounts are included in foreign exchange impact of lease liabilities and forward contracts in the condensed consolidated statements of operations.

During the year ended March 31, 2025, the Company ceased manufacturing operations at its Torrance, California facility as a part of its strategy to enhance its operating efficiencies. This represented a significant change to the use of this right-of-use asset, which required a reassessment of the Company’s asset groups. The Company concluded that this right-of-use asset was no longer part of the Hard Parts asset group. The Company performed a test for recoverability (using Level 3 inputs) which resulted in no impairment at June 30, 2025. Any future changes to the assumptions and estimates from those anticipated may affect the carrying value of right-of-use assets and could result in impairment charges.

During the nine months ended December 31, 2024, the Company ceased manufacturing operations at its Torrance, California facility as a part of its on-going strategy to utilize its global footprint to enhance its operating efficiencies. This represented a significant change to the use of this right-of-use asset, which required a reassessment of the Company’s asset groups. The Company concluded that this right-of-use asset was no longer part of the Hard Parts asset group. The Company performed a test for recoverability (using Level 3 inputs) which resulted in no impairment at December 31, 2024. Any future changes to the assumptions and estimates from those anticipated may affect the carrying value of right-of-use assets and could result in impairment charges.

Balance sheet information for leases is as follows:

Leases	Classification	~~December 31, 2024~~	June 30,2025	March 31, ~~2024~~2025
Assets:
Operating	Operating lease assets	$	6768,~~552~~281,000	$	8366,~~973~~603,000
Finance	Plant and equipment		35,~~710~~309,000		4,~~611~~296,000
Total leased assets		$	7173,~~262~~590,000	$	8870,~~584~~899,000
Liabilities:
Current
Operating	Operating lease liabilities	$	910,~~308~~196,000	$	89,~~319~~982,000
Finance	Other current liabilities		1,~~289~~321,000		1,~~585~~222,000
Long-term
Operating	Long-term operating lease liabilities		6663,~~833~~056,000		7265,~~240~~308,000
Finance	Other liabilities		13,~~560~~268,000		1,~~893~~954,000
Total lease liabilities		$	7877,~~990~~841,000	$	8478,~~037~~466,000

Lease cost recognized in the condensed consolidated statements of operations is as follows:

	Three Months Ended	~~Three Months Ended~~					~~Nine Months Ended~~
		December 31,					December 31,
	June 30,
		2024			2023		2024		2023
		2025			2024
Lease cost
Operating lease cost	$	$3,490,000	~~3,391,000~~	$	$3,759,000	~~3,740,000~~	$	~~10,673,000~~	$	~~11,243,000~~
Short-term lease cost		216,000	~~267,000~~		312,000	~~274,000~~		~~960,000~~		~~917,000~~
Variable lease cost		133,000	~~83,000~~		164,000	~~138,000~~		~~338,000~~		~~470,000~~
Finance lease cost:
Amortization of finance lease assets		355,000	~~287,000~~		358,000	~~361,000~~		~~940,000~~		~~1,155,000~~
Interest on finance lease liabilities		74,000	~~44,000~~		51,000	~~51,000~~		~~140,000~~		~~170,000~~
Total lease cost	$	$4,268,000	~~4,072,000~~	$	$4,644,000	~~4,564,000~~	$	~~13,051,000~~	$	~~13,955,000~~

Maturities of lease commitments at ~~December~~June 3130, ~~2024~~2025 by fiscal year were as follows:

Maturity of lease liabilities		Operating Leases				Finance Leases				Total
Maturity of lease liabilities by fiscal year		Operating Leases				Finance Leases				Total
2025 - remaining three months		$	3,315,000			$	427,000			$	3,742,000
2026- remaining nine months	$	10,643,000			$	1,279,000			$	11,922,000
2026			13,439,000				1,190,000				14,629,000
2027		12,331,000				1,304,000				13,635,000
2027			11,662,000				699,000				12,361,000
2028		11,672,000				1,049,000				12,721,000
2028			11,126,000				483,000				11,609,000
2029		11,179,000				818,000				11,997,000
2029			11,132,000				288,000				11,420,000
2030		11,378,000				740,000				12,118,000
Thereafter		32,135,000	~~43,485,000~~			92,000	~~72,000~~			32,227,000	~~43,557,000~~
Total lease payments		89,338,000	~~94,159,000~~			5,282,000	~~3,159,000~~			94,620,000	~~97,318,000~~
Less amount representing interest		(16,086,000	~~(18,018,000~~)	)		(693,000	~~(310,000~~)	)		(16,779,000	~~(18,328,000~~)	)
Present value of lease liabilities	$	$73,252,000	~~76,141,000~~		$	$4,589,000	~~2,849,000~~		$	$77,841,000	~~78,990,000~~

Other information about leases is as follows:

	December 31, 2024			March 31, 2024
	June 30, 2025			March 31, 2025
Lease term and discount rate
Weighted-average remaining lease term (years):
Finance leases	4.0	~~3.0~~		3.2	~~2.8~~
Operating leases	7.1	~~7.6~~		7.3	~~8.3~~
Weighted-average discount rate:
Finance leases	7.1	~~6.8~~%	%	7.0	~~6.4~~%	%
Operating leases	5.8	~~5.8~~%	%	5.8	~~5.8~~%	%

10. Accounts Receivable Discount Programs

The Company uses accounts receivable discount programs offered by certain customers and their respective banks. Under these programs, the Company may sell those customers’ receivables to those banks at a discount to be agreed upon at the time the receivables are sold. These discount arrangements allow the Company to accelerate receipt of payment on customers’ receivables.

The following is a summary of accounts receivable discount programs:

		Nine Months Ended
	Three Months Ended
		December 31,
	June 30,
		2024				2023
		2025				2024
Receivables discounted	$	$168,194,000	~~488,505,000~~		$	$144,541,000	~~465,073,000~~
Weighted average number of days collection was accelerated		345	~~342~~			342	~~334~~
Annualized weighted average discount rate		5.7	~~6.3~~%	%		6.9	~~6.8~~%	%
Amount of discount recognized as interest expense	$	$9,158,000	~~29,202,000~~		$	$9,507,000	~~29,395,000~~

11. Supplier Finance Programs

The Company utilizes a supplier finance program, which allows certain of the Company’s suppliers to sell their receivables due from the Company to participating financial institutions at the sole discretion of both the supplier and the financial institutions. The program is administered by a third party. Commitments from participating financial institutions that are available to suppliers under this program ~~increased~~were to $2730,000,000 ~~from~~at ~~$15~~June 30,~~000,000~~ ~~during~~2025 ~~the~~and ~~three~~March ~~months ended December~~ 31, ~~2024~~2025. The Company has no economic interest in the sale of these receivables and no direct relationship with the financial institution. Payments to the third-party administrator are based on services rendered and are not related to the volume or number of financing agreements between suppliers, financial institution, and the third-party administrator. The Company is not a party to agreements negotiated between participating suppliers and the financial institution. The Company's obligations to its suppliers, including amounts due and payment terms, are not affected by a supplier's decision to participate in this program. The Company does not provide guarantees and there are no assets pledged to the financial institution or the third-party administrator for the committed payment in connection with this program. At ~~December~~June 30, 2025 and March 31, ~~2024~~2025, the Company had $31,~~809~~292,000 and $33,661,000, respectively, of outstanding supplier obligations confirmed as valid under this program, included in accounts payable in the condensed consolidated balance ~~sheet~~sheets.

12. Net Income (Loss) per Share

Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted net income (loss) per share includes the effect, if any, from the potential exercise or conversion of securities, such as stock options, Warrants, and Convertible Notes (as defined in Note 7), which would result in the issuance of incremental shares of common stock to the extent such impact is not anti-dilutive.

The following presents a reconciliation of basic and diluted net income (loss) per share:

		Three Months Ended						~~Nine Months Ended~~
		December 31,						December 31,
		June 30,
		2024			2023			2024			2023
		2025			2024
Net income (loss)	$	$3,042,000	~~2,291,000~~	$	$(18,085,000	~~(47,214,000~~)	)	$	~~(18,748,000~~	)	$	~~(50,582,000~~	)
Basic shares		19,369,060	~~19,783,170~~		19,674,539	~~19,634,306~~			~~19,739,481~~			~~19,580,960~~
Effect of potentially dilutive securities		548,603	~~633,788~~		-	-			-			-
Diluted shares		19,917,663	~~20,416,958~~		19,674,539	~~19,634,306~~			~~19,739,481~~			~~19,580,960~~
Net income (loss) per share:
Basic net income (loss) per share	$	$0.16	~~0.12~~	$	$(0.92	~~(2.40~~)	)	$	~~(0.95~~	)	$	~~(2.58~~	)
Diluted net income (loss) per share	$	$0.15	~~0.11~~	$	$(0.92	~~(2.40~~)	)	$	~~(0.95~~	)	$	~~(2.58~~	)

Potential common shares that would have the effect of increasing diluted net income per share or decreasing diluted net loss per share are considered to be anti-dilutive and as such, these shares are not included in calculating diluted net income (loss) per share. For the three months ended ~~December~~June 3130, ~~2024~~2025, there were 151,~~526~~049,341 of potential common shares not included in the calculation of diluted net income per share because their effect was anti-dilutive. For the ~~nine~~three months ended ~~December~~June 3130, 2024, there were 2,~~516~~285,~~729~~834 of potential common shares not included in the calculation of diluted net loss per share because their effect was anti-dilutive. For the three and nine months ended December 31, 2023, there were 2,130,615, respectively, of potential common shares not included in the calculation of diluted net loss per share because their effect was anti-dilutive.

In addition, for the three ~~and nine~~ months ended ~~December~~June 3130, 2025 and 2024, there were 2,~~523~~646,~~304~~535 and 2,~~464~~405,~~622~~941, respectively, of potential common shares not included in the calculation of diluted net income (loss) per share under the “if-converted” method for the Convertible Notes because their effect was anti-dilutive. In addition, for the three and nine months ended December 31, 2023, there were 2,293,926, respectively, of potential common shares not included in the calculation of diluted net loss per share under the “if-converted” method for the Convertible Notes because their effect was anti-dilutive. The potential common shares related to the Warrants issued in connection with the Convertible Notes (see Note 7) are anti-dilutive until they become exercisable and as of ~~December~~June 3130, ~~2024~~2025, the Warrants were not exercisable.

13. Income Taxes

The Company recorded income tax expense of $12,~~115~~425,000, or an effective tax rate of 3244.74%, and ~~$37,281,000, or an effective tax rate of (375.3)%, for the three months ended December 31, 2024 and 2023, respectively. The Company recorded an~~ income tax ~~expense~~benefit of $1178,~~849,~~000, or an effective tax rate of ~~(10.9)~~1%, ~~and $37,226,000, or an effective tax rate of (278.7)%,~~ for the ~~nine~~three months ended ~~December~~June 3130, ~~2024~~2025 and ~~2023~~2024, respectively. The effective tax rate for the three ~~and nine~~ months ended ~~December~~June 3130, ~~2024~~2025, was primarily impacted by ~~(i) foreign income taxed at rates that are different from~~ the ~~federal statutory rate, (ii) the~~ change in valuation allowance, ~~and~~on ~~(iii)~~certain ~~specific~~ jurisdictions' ~~that~~deferred ~~the Company does not expect to recognize the benefit of losses. The Company’s effective~~ tax ~~rate~~assets ~~for~~resulting ~~the~~from current ~~three~~year activities and ~~nine~~foreign ~~months~~income ~~ended~~taxed ~~December~~at ~~31,~~rates ~~2023~~that ~~was~~are ~~primarily~~different ~~impacted~~from by the ~~establishment~~federal ofstatutory ~~a valuation allowance on deferred tax assets that were not expected to be realized~~rate.

Management continues to monitor its valuation allowance position in its various jurisdictions. In assessing the need for a valuation allowance, the Company considers all positive and negative evidence, including scheduled reversals of deferred tax liabilities, projected future taxable income, past financial performance, and tax planning strategies. Based on this analysis, the Company determined that it is more likely than not that certain deferred tax assets will not be realized. As a result, the Company ~~maintained~~continued ~~its~~to have valuation ~~allowance~~allowances on its U.S. ~~The~~and ~~Company~~one ~~will~~of ~~continue~~its toMexican ~~monitor~~subsidiaries’ ~~the~~deferred ~~need~~tax ~~for~~assets. aThe ~~valuation~~Company ~~allowance~~will monitor its position in future periods,. ~~considering~~Should ~~any~~the ~~changes~~actual inamount ~~circumstances~~differ ~~that~~from ~~may~~the ~~affect~~Company’s estimates, the ~~realizability~~amount of ~~deferred~~any ~~tax~~valuation ~~assets~~allowance could be impacted.

The Company and its subsidiaries file income tax returns for the U.S. federal, various state, and foreign jurisdictions with varying statutes of limitations. At June 30, 2025, the Company remains subject to examination for fiscal years ended March 31, 2022 and forward. The Company believes no significant changes in the unrecognized tax benefits will occur within the next 12 months.

On July 4, 2025, the One Big Beautiful Bill Act ("OBBBA") was signed into law in the U.S. The OBBBA includes a broad range of tax reform provisions, including making permanent key elements of the Tax Cuts and Jobs Act of 2017, which may affect the Company's financial position and results of operations. The Company is currently evaluating the impact of these provisions on the Company's effective tax rate and deferred tax assets for future periods.

The Company and its subsidiaries file income tax returns for the U.S. federal, various state, and foreign jurisdictions with varying statutes of limitations. The Company was previously under examination by the State of California for fiscal years ended March 31, 2020, 2021 and 2022. During the nine months ended December 31, 2024, this audit was concluded with no changes required to the Company’s filed income tax returns. At December 31, 2024, the Company remains subject to examination from the fiscal years ended March 31, 2020 and forward. The Company believes no significant changes in the unrecognized tax benefits will occur within the next 12 months.

14. Financial Risk Management and Derivatives

Purchases and expenses denominated in currencies other than the U.S. dollar, which are primarily related to the Company’s overseas facilities, expose the Company to market risk from material movements in foreign exchange rates between the U.S. dollar and the foreign currencies. The Company’s primary risk exposure is from fluctuations in the value of the Mexican peso and to a lesser extent the Chinese yuan. To mitigate these risks, the Company enters into forward foreign currency exchange contracts to exchange U.S. dollars for these foreign currencies. The extent to which forward foreign currency exchange contracts are used, is modified periodically in response to the Company’s estimate of market conditions and the terms and length of anticipated requirements.

The Company enters into forward foreign currency exchange contracts in order to reduce the impact of foreign currency fluctuations and not to engage in currency speculation. The use of derivative financial instruments allows the Company to reduce its exposure to the risk that the eventual cash outflow resulting from funding the expenses of the foreign operations will be materially affected by changes in exchange rates between the U.S. dollar and the foreign currencies. The Company does not hold or issue financial instruments for trading purposes. The Company designates forward foreign currency exchange contracts for forecasted expenditure requirements to fund foreign operations.

The Company had forward foreign currency exchange contracts with a U.S. dollar equivalent notional value of $5042,~~947~~531,000 and $5445,~~092~~921,000 at ~~December~~June 3130, ~~2024~~2025 and March 31, ~~2024~~2025, respectively. These contracts generally have a term of one year or less, at rates agreed at the inception of the contracts. The counterparty to these derivative transactions is a major financial institution with investment grade credit rating; however, the Company is exposed to credit risk with this institution. The credit risk is limited to the potential unrealized gains (which offset currency fluctuations adverse to the Company) in any such contract should this counterparty fail to perform as contracted. Any changes in the fair values of forward foreign currency exchange contracts are included in foreign exchange impact of lease liabilities and forward contracts in the condensed consolidated statements of operations.

The following shows the effect of derivative instruments on the condensed consolidated statements of operations:

	~~Foreign Exchange Impact of Lease Liabilities and Forward Contracts~~	Foreign Exchange Impact of Lease Liabilities and Forward Contracts
	~~Three Months Ended~~	Three Months Ended					~~Nine Months Ended~~
Derivatives Not Designated as	~~December 31,~~	June 30,					~~December 31,~~
Hedging Instruments	~~2024~~	2025		~~2023~~	2024		~~2024~~			~~2023~~
(Loss) gain from forward foreign currency exchange contracts	$	(585,000	)	$	541,000		$	(7,404,000	)	$	(1,771,000	)
Gain (loss) from forward foreign currency exchange contracts	$	4,346,000		$	(5,369,000	)

The changes in the fair ~~value~~values of ~~the~~ forward foreign currency exchange contracts ofare ~~$4,888,000 is~~ included in ~~other~~foreign ~~current~~exchange impact of lease liabilities and forward contracts in the condensed consolidated ~~balance~~statements ~~sheets~~of atcash ~~December~~flows 31for the three months ended June 30, 2025 and 2024. The fair value of the forward foreign currency exchange contracts of $2,~~516~~683,000 is included in prepaid expenses and other current assets in the condensed consolidated balance sheets at ~~March~~June 3130, ~~2024~~2025. The ~~changes in the~~ fair ~~values~~value of the forward foreign currency exchange contracts ~~are~~of $1,663,000 is included in ~~foreign~~other ~~exchange~~current ~~impact of lease~~ liabilities ~~and forward contracts~~ in the condensed consolidated ~~statements~~balance ofsheets ~~cash~~at ~~flows~~March ~~for the nine months ended December~~ 31, ~~2024 and 2023~~2025.

15. Fair Value Measurements

The following summarizes financial assets and liabilities measured at fair value, by level within the fair value hierarchy:

	December 31, 2024								March 31, 2024
			June 30, 2025									March 31, 2025
			Fair Value Measurements								~~Fair Value Measurements~~	Fair Value Measurements
			Using Inputs Considered as								~~Using Inputs Considered as~~	Using Inputs Considered as
	~~Fair Value~~	Fair Value	~~Level 1~~	Level 1	~~Level 2~~	Level 2	~~Level 3~~	Level 3	~~Fair Value~~	Fair Value	~~Level 1~~		Level 1	~~Level 2~~		Level 2	~~Level 3~~		Level 3
Assets
Short-term investments
Mutual funds	$	12,~~909~~011,000	$	12,~~909~~011,000	$	-	$	-	$	1,~~837~~881,000	$	~~1,837,000~~$	1,881,000	$	-$	-	$	-$	-
Prepaid expenses and other current assets
Forward foreign currency exchange contracts		-2,683,000		-		-2,683,000		-		~~2,516,000~~-		-	-		~~2,516,000~~	-		-	-
Liabilities
Other current liabilities
Deferred compensation		12,~~909~~011,000		12,~~909~~011,000		-		-		1,~~837~~881,000		~~1,837,000~~	1,881,000		-	-		-	-
Forward foreign currency exchange contracts		~~4,888,000~~-		-		~~4,888,000~~-		-		-1,663,000		-	-		-	1,663,000		-	-
Convertible notes, related party
Convertible notes, related party Compound Net Derivative Liability		9,260,000		-		-		9,260,000		7,470,000			-			-			7,470,000
Compound Net Derivative Liability		4,950,000		-		-		4,950,000		7,410,000		-			-			7,410,000

Short-term Investments and Deferred Compensation

The Company’s short-term investments, which fund its deferred compensation liabilities, consist of investments in mutual funds. These investments are classified as Level 1 as the shares of these mutual funds trade with sufficient frequency and volume to enable the Company to obtain pricing information on an ongoing basis.

Forward Foreign Currency Exchange Contracts

The forward foreign currency exchange contracts are primarily measured based on the foreign currency spot and forward rates quoted by the banks or foreign currency dealers (~~See~~see Note 14).

Compound Net Derivative Liability

The Company estimates the fair value of the Compound Net Derivative Liability (see Note 7) using Level 3 inputs and the Monte Carlo simulation model at the balance sheet date. The Monte Carlo simulation model requires the input of subjective assumptions including the expected volatility of the underlying stock. These subjective assumptions are based on both historical and other information. Changes in the values assumed and used in the model can materially affect the estimate of fair value. This amount is recorded within convertible notes, related party in the condensed consolidated balance sheets at ~~December~~June 3130, ~~2024~~2025 and March 31, ~~2024~~2025. Any changes in the fair value of the Compound Net Derivative Liability are recorded in change in fair value of compound net derivative liability in the condensed consolidated statements of operations and condensed consolidated statements of cash flows.

The following assumptions were used to determine the fair value of the Compound Net Derivative Liability:

	December 31, 2024			March 31, 2024
	June 30, 2025			March 31, 2025
Risk free interest rate	3.70	~~4.35~~%	%	3.91	~~4.36~~%	%
Cost of equity	21.40	~~23.40~~%	%	21.30	~~23.20~~%	%
Weighted average cost of capital	15.60	~~14.40~~%	%	14.90	~~14.90~~%	%
Expected volatility of the Company's common stock	47.50	~~40.00~~%	%	40.00	~~50.00~~%	%
EBITDA volatility	35.00	~~40.00~~%	%	45.00	~~40.00~~%	%

The following summarizes the activity for Level 3 fair value measurements:

	Three Months Ended	~~Three Months Ended~~							~~Nine Months Ended~~
		December 31,							December 31,
	June 30,
		2024					2023		2024			2023
		2025				2024
Beginning balance	$	$7,470,000	~~5,210,000~~		$	7,410,000	$	~~8,960,000~~	$	~~7,410,000~~		$	~~8,430,000~~
Changes in fair value of Compound Net Derivative Liability included in earnings		1,790,000	~~(260,000~~	)		(2,580,000	)	~~1,160,000~~		~~(2,460,000~~	)		~~1,690,000~~
Ending balance	$	$9,260,000	~~4,950,000~~		$	4,830,000	$	~~10,120,000~~	$	~~4,950,000~~		$	~~10,120,000~~

During the three ~~and nine~~ months ended ~~December~~June 3130, ~~2024~~2025, the Company had no significant measurements of assets or liabilities at fair value on a nonrecurring basis subsequent to their initial recognition.

The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate their fair value due to the short-term nature of these instruments. The carrying amounts of the revolving loan and other long-term liabilities approximate their fair value based on the variable nature of interest rates and current rates for instruments with similar characteristics. At ~~December~~June 3130, ~~2024~~2025 and March 31, ~~2024~~2025, the net carrying amount of the Convertible Notes was $3240,~~377~~844,000 and $3035,~~776~~207,000, respectively (see Note 7). The estimated fair value of the Company’s Convertible Notes was $3651,~~168~~514,000 and $3842,~~276~~398,000 using Level 3 inputs at ~~December~~June 3130, ~~2024~~2025 and March 31, ~~2024~~2025, respectively.

16. Share-based Payments

Stock Options

~~The~~During ~~Company did not grant any options to purchase shares of its common stock during~~ the ~~nine~~three months ended ~~December~~June 3130, ~~2024. The~~2025 ~~Company~~and ~~granted~~2024, no options to purchase ~~132,133~~ shares of ~~common stock during~~ the ~~nine~~Company’s ~~months~~common ~~ended~~stock ~~December~~were ~~31, 2023~~granted.

The following assumptions were used to derive the weighted average fair value of the stock options granted:

	Nine Months Ended
	December 31,
	2023
Weighted average risk free interest rate		4.53	%
Weighted average expected holding period (years)		6.57
Weighted average expected volatility		51.29	%
Weighted average expected dividend yield		-
Weighted average fair value of options granted	$	3.75

The following is a summary of stock option transactions:

	Number of				Weighted Average
	Number of Shares				Weighted AverageExercise Price
	Shares				Exercise Price
Outstanding at March 31, 2025	1,053,561			$	20.20
Outstanding at March 31, 2024		1,108,017			$	20.29
Forfeited/Cancelled	(4,220	)		$	22.64
Granted		-			$	-
Outstanding at June 30, 2025	1,049,341			$	20.20
Exercised		-			$	-
Forfeited/Cancelled		(17,723	)		$	20.13
Expired		(36,733	)		$	22.93
Outstanding at December 31, 2024		1,053,561			$	20.20

At ~~December~~June 3130, ~~2024~~2025, options to purchase 87,288 shares of common stock were unvested at a weighted average exercise price of $9.32.

At ~~December~~June 3130, ~~2024~~2025, there was $~~282~~201,000 of total unrecognized compensation expense related to unvested stock option awards, which will be recognized over the weighted average remaining vesting period of approximately 1.72 years.

Restricted Stock Units (“RSUs”)

During the three months ended June 30, 2025 and 2024, the Company granted 428,552 and 207,050, respectively, of time-based vesting RSUs, based on the closing market price on the grant date.

Restricted Stock Units (“RSUs”)

During the nine months ended December 31, 2024 and 2023, the Company granted 453,453 and 100,624, respectively, of time-based vesting RSUs, based on the closing market price on the grant date.

The following is a summary of non-vested RSUs:

	Number of Shares				Weighted ~~AverageGrant~~Average Grant Date ~~FairValue~~Fair Value
Outstanding at March 31, 2024		240,923			$	12.23
Outstanding at March 31, 2025	505,373			$	7.26
Granted	428,552	~~453,453~~		$	$9.76	~~6.58~~
Vested	(121,364	~~(184,850~~)	)	$	$9.49	~~12.02~~
Forfeited/Cancelled	(580	~~(4,069~~)	)	$	$7.73	~~8.72~~
Outstanding at December 31, 2024		505,457			$	7.26
Outstanding at June 30, 2025	811,981			$	8.25

At ~~December~~June 3130, ~~2024~~2025, there was $25,~~819~~931,000 of unrecognized compensation expense related to RSUs, which will be recognized over the weighted average remaining vesting period of approximately 2.17 years.

Performance Stock Units (“PSUs”)

During the ~~nine~~three months ended ~~December~~June 3130, ~~2024~~2025, the Company granted ~~258~~353,~~983~~778 PSUs (at target performance levels), ~~which cliff vest after a three-year performance period, subject to continued employment. The number of shares earned at the end of the three-year performance period will vary,~~ based ~~only~~ on ~~actual performance, from 0% to 150% of~~ the ~~target~~Company’s ~~number~~stock ofprice ~~PSUs~~or ~~granted~~a ~~depending on the Company’s~~ total shareholder return (“TSR”) ~~percentile~~market ~~rank relative to that of a peer group over the performance period~~conditions. ~~TSR~~During ~~is measured based on a comparison of~~ the ~~closing~~three ~~price~~months onended ~~the~~June ~~first~~30, ~~trading~~2024, ~~day of~~ the ~~performance~~Company ~~period~~granted ~~and~~155,391 ~~the~~PSUs ~~average~~(at ~~closing~~target ~~price over the last 30 trading days of the~~ performance ~~period.~~levels), ~~TSR~~based ison ~~considered~~ a TSR market condition. ~~because~~All itPSUs ~~measures~~granted ~~the~~have ~~Company’s~~a ~~return~~three-year ~~against the~~ performance ~~of the Russell 3000~~period, ~~excluding~~subject ~~companies~~to ~~classified~~continued ~~as financials and real estate and companies with a market capitalization of more than $600 million, over a given period of time~~employment.

Stock ~~During~~Price ~~the nine months ended December 31, 2023, the Company granted 585,583~~ PSUs, which vest within a three-year period, subject to continued employment, as follows: (i) if the stock price is greater than or equal to $10.00 per share, then 1/3 of the grant will vest, (ii) if the stock price is greater than or equal to $15.00 per share then the next 1/3 of the grant will vest, and (iii) if the stock price is greater than or equal to $20.00 per share then the final 1/3 of the grant will vest. Recipients are eligible to vest in between 50% and 150% of the third tranche by achieving a stock price between $17.50 and $25.00 per share (each stock price target must be met for 30 consecutive trading days).

During the three months ended June 30, 2025, the Company granted 176,893 PSUs (at target performance levels), which vest as follows: (i) if the stock price is greater than or equal to $15.00 per share, then 1/3 of the grant will vest, (ii) if the stock price is greater than or equal to $17.00 per share then the next 1/3 of the grant will vest, and (iii) if the stock price is greater than or equal to $20.00 per share then the final 1/3 of the grant will vest. Recipients are eligible to vest in between 50% and 150% of the third tranche by achieving a stock price between $18.00 and $22.00 per share (each stock price target must be met for thirty consecutive trading days). The Company calculated the fair value of these PSUs individually for each tranche using the Monte Carlo Simulation Model at the grant date. Compensation cost is recognized over the estimated derived service period. Compensation cost related to these awards will not be adjusted even if the market condition is not met.

During the three months ended June 30, 2024, the Company did not grant any PSUs based on the Company’s stock price.

TSR PSUs

During the three months ended June 30, 2025 and 2024, the Company granted 176,885 and 155,391 PSUs (at target performance levels), respectively, which cliff vest and the number of shares earned at the end of the three-year performance period will vary, based only on actual performance, from 0% to 150% of the target number of PSUs granted, depending on the Company’s TSR percentile rank relative to that of a peer group over the performance period. TSR is measured based on a comparison of the closing price on the first trading day of the performance period and the average closing price over the last 30 trading days of the performance period. TSR is considered a market condition because it measures the Company’s return against the performance of the Russell 3000, excluding companies classified as financials and real estate and companies with a market capitalization of more than $600 million, as of the start of the performance period. Compensation cost is determined at the grant date and recognized on a straight-line basis over the requisite service period to the extent the conditions are deemed probable. Compensation cost related to the TSR award will not be adjusted even if the market condition is not met.

The ~~Company calculated the~~ fair value of ~~these~~ PSUs ~~individually~~subject ~~for~~to ~~each~~a ~~tranche~~market ~~using~~condition ~~the Monte Carlo Simulation Model at the grant date. Compensation cost~~ is ~~recognized~~determined ~~over~~using the ~~estimated~~Monte ~~derived~~Carlo ~~service~~simulation ~~period~~model. ~~Compensation cost related to these awards will not be adjusted even if the market condition is not met.~~ The following table summarizes the assumptions used in determining the fair value of ~~these~~the awards subject to market conditions:

		Nine Months Ended
	Three Months EndedJune 30,
		December 31,
		2025				2024
		2024				2023
Risk free interest rate		3.86	%			4.45	%
Risk free interest rate			4.21-4.45	%			4.32-4.35	%
Expected life in years		0.7-3.0				3
Expected life in years			3.0				0.2-1.8
Expected volatility of the Company's common stock		66.80	%			59.80	%
Expected volatility of the Company's common stock			59.8-62.8	%			54.2-55.1	%
Average correlation coefficient of peer companies		15.70	%			16.50	%
Average correlation coefficient of peer companies			16.5-17.4	%			-	%
Expected dividend yield		-				-
Expected dividend yield			-				-
Grant date fair value	$	7.33-12.68			$	8.65
Grant date fair value		$	8.65-8.88			$	3.57-8.37

The following is a summary of non-vested PSUs:

		Number ofShares				Weighted AverageGrant Date FairValue
	Number of Shares					Weighted Average Grant Date Fair Value
Outstanding at March 31, 2024			773,923			$	7.73
Outstanding at March 31, 2025		764,387			$	7.42
Granted (1)			269,935			$	8.74
Granted		353,778			$	10.57
Vested		(43,917	~~(32,848~~)	)	$	$14.55	~~22.27~~
Forfeited/Cancelled		(76,101	~~(53,299~~)	)	$	$13.65	~~22.89~~
Outstanding at December 31, 2024			957,711			$	6.83
Outstanding at June 30, 2025		998,147			$	7.74

~~(1)~~At June 30, 2025, there was $5,256,000 of unrecognized compensation expense related to these awards, which will be recognized over the weighted average remaining vesting period of approximately 2.2 years.

Granted includes 10,952 additional PSUs issued in connection with the vesting of the Company’s June 2021 PSU grant based on actual Company performance metrics exceeding target performance levels.

At December 31, 2024, there was $2,248,000 of unrecognized compensation expense related to these awards, which will be recognized over the weighted average remaining vesting period of approximately 2.2 years.

17. Commitments and Contingencies

Warranty Returns

The Company allows its customers to return goods that their consumers have returned to them, whether or not the returned item is defective (“warranty returns”). The Company accrues an estimate of its exposure to warranty returns based on a historical analysis of the level of this type of return as a percentage of unit sales. Amounts charged to expense for these warranty returns are considered in arriving at the Company’s net sales.

The following summarizes the changes in the warranty returns:

		Three Months Ended							Nine Months Ended
	Three Months EndedJune 30,
		December 31,							Dece,ber 31,
		2025				2024
		2024				2023			2024			2023
Balance at beginning of period	$	19,677,000			$	19,326,000
Balance at beginning of period		$	16,649,000			$	16,197,000		$	19,326,000		$	19,830,000
Charged to expense		38,453,000				33,352,000
Charged to expense			38,116,000				34,532,000			113,212,000			102,666,000
Amounts processed		(39,999,000	)			(37,632,000	)
Amounts processed			(35,390,000	)			(34,599,000	)		(113,163,000	)		(106,366,000	)
Balance at end of period	$	18,131,000			$	15,046,000
Balance at end of period		$	19,375,000			$	16,130,000		$	19,375,000		$	16,130,000

At ~~December~~June 3130, ~~2024~~2025 and March 31, ~~2024~~2025, the Company’s total warranty return accrual was $1918,~~375~~131,000 and $19,~~326~~677,000, respectively, of which $47,~~840~~222,000 and $56,~~667~~478,000, respectively, was included in the customer returns RGA issued within accounts receivable—net and $1410,~~535~~909,000 and $13,~~659~~199,000, respectively, was included in the customer finished goods returns accrual in the condensed consolidated balance sheets.

Contingencies

The Company is subject to various lawsuits and claims. In addition, government agencies and self-regulatory organizations have the ability to conduct periodic examinations of and administrative proceedings regarding the Company’s business, and its compliance with law, code, and regulations related to matters including, but not limited to, environmental, information security, taxes, levies, tariffs and such. The Company has an immaterial amount accrued related to these exposures to various lawsuits, claims, examinations, and ~~claims~~administrative proceedings.

18. Segment Information

The Company has identified its Chief Executive Officer as its chief operating decision maker (“CODM”). The Company has identified its operating segments based on the nature of the products the Company sells, the Company’s ~~three~~organizational and management reporting structure, and the operating ~~segments~~results that are asregularly ~~follows:~~reviewed by the Company’s CODM to make decisions about the resources to be allocated to the business units and to assess performance. The CODM primarily uses operating income to evaluate the performance of the Company’s operating segments and to allocate resources.

The Company’s three operating segments are:

●

Hard Parts, which includes (i) light duty rotating electric products such as alternators and starters, (ii) wheel hub products, (iii) brake-related products, including brake calipers, brake boosters, brake rotors, brake pads and brake master cylinders, and (iv) turbochargers,

●

Test Solutions and Diagnostic Equipment, which includes (i) applications for combustion engine vehicles, including bench-top testers for alternators and starters, (ii) equipment for the pre- and post-production of electric vehicles, and (iii) software emulation of power system applications for the electrification of all forms of transportation (including automobiles, trucks, the emerging electrification of systems within the aerospace industry, and electric vehicle charging stations), and

●

Heavy Duty, which includes non-discretionary automotive aftermarket replacement hard parts for heavy- duty truck, industrial, marine, and agricultural applications.

The Company’s Hard Parts operating segment meets the criteria of a reportable segment. The Test Solutions and Diagnostic Equipment and Heavy Duty segments are not material, and are not required to be separately reported~~, and are included within the “all other” category~~.

Financial information relating to the Company’s segments is as follows:

		Three Months Ended December 31, 2024
	Three Months Ended
		Hard Parts				All Other			Total
	June 30,
Net sales to external customers		$	174,548,000			$	11,628,000		$	186,176,000
		2025				2024
Intersegment sales			344,000				222,000			566,000
Net sales to external customers for Hard Parts reportable segment	$	174,889,000			$	158,187,000
Operating income (loss)			19,069,000	(1)			(1,515,000	)		17,554,000
Intersegment sales for Hard Parts reportable segment		258,000				32,000
Depreciation and amortization			2,321,000				211,000			2,532,000
Total net sales for Hard Parts reportable segment		175,147,000				158,219,000
Segment assets			962,855,000				54,855,000			1,017,710,000
Reconciliation of net sales
Capital expenditures			601,000				68,000			669,000
Other net sales (1)		13,475,000				11,700,000
Elimination of intersegment net sales		(258,000	)			(32,000	)
Total consolidated net sales	$	188,364,000			$	169,887,000
Less (2):
Material, labor, and overhead expenses		113,895,000				109,217,000
Logistic expenses (3)		30,665,000				22,778,000
Revaluation of cores on customers' shelves		1,026,000				394,000
Foreign exchange impact of lease liabilities and forward contracts		(8,348,000	)			11,078,000
Other segment items (4)		19,477,000				21,211,000
Total operating income (loss) for Hard Parts reportable segment	$	18,432,000			$	(6,459,000	)
Reconciliation of profit (loss)
Other operating income (loss) (1)		1,633,000				(6,000	)
Elimination of intersegment operating income		4,000				9,000
Interest expense, net		(12,812,000	)			(14,387,000	)
Change in fair value of compound net derivative liability		(1,790,000	)			2,580,000
Total consolidated income (loss) before income tax expense (benefit)	$	5,467,000			$	(18,263,000	)
Reconciliations of other significant items and assets:
Depreciation and amortization
Depreciation and amortization for Hard Parts reportable segment (5)	$	2,232,000			$	2,525,000
Other depreciation and amortization (1)		217,000				204,000
Total consolidated depreciation and amortization	$	2,449,000			$	2,729,000
Capital Expenditures
Captial expenditures for Hard Parts reportable segment	$	394,000			$	253,000
Other capital expenditures (1)		413,000				237,000
Total consolidated capital expenditures	$	807,000			$	490,000

		Three Months Ended December 31, 2023
Assets		June 30, 2025				March 31, 2025
		Hard Parts				All Other			Total
Total assets for Hard Parts reportable segment	$	981,161,000			$	967,178,000
Net sales to external customers		$	161,254,000			$	10,608,000		$	171,862,000
Other assets (1)		60,688,000				58,355,000
Intersegment sales			242,000				116,000			358,000
Elimination of intersegment assets		(68,499,000	)			(67,897,000	)
Operating income (loss)			9,993,000	(1)			(473,000	)		9,520,000
Total consolidated assets	$	973,350,000			$	957,636,000
Depreciation and amortization			2,557,000				321,000			2,878,000
Segment assets			1,005,470,000				51,965,000			1,057,435,000
Capital expenditures			221,000				72,000			293,000

	Nine Months Ended December 31, 2024
	Hard Parts			All Other			Total
Net sales to external customers	$	527,412,000		$	36,837,000		$	564,249,000
Intersegment sales		840,000			794,000			1,634,000
Operating income (loss)		23,893,000	(1)		(322,000	)		23,571,000
Depreciation and amortization		7,247,000			615,000			7,862,000
Capital expenditures		1,402,000			314,000			1,716,000

	Nine Months Ended December 31, 2023
	Hard Parts			All Other			Total
Net sales to external customers	$	495,422,000		$	32,784,000		$	528,206,000
Intersegment sales		442,000			249,000			691,000
Operating income (loss)		36,702,000	(1)		(2,852,000	)		33,850,000
Depreciation and amortization		7,825,000			1,019,000			8,844,000
Capital expenditures		352,000			110,000			462,000

	Three Months Ended						Nine Months Ended
	December 31,						December 31,
Net sales	2024			2023			2024			2023
Total net sales for reportable segment	$	174,892,000		$	161,496,000		$	528,252,000		$	495,864,000
Other net sales		11,850,000			10,724,000			37,631,000			33,033,000
Elimination of intersegment net sales		(566,000	)		(358,000	)		(1,634,000	)		(691,000	)
Total consolidated net sales	$	186,176,000		$	171,862,000		$	564,249,000		$	528,206,000

	Three Months Ended						Nine Months Ended
	December 31,						December 31,
Profit or loss	2024			2023			2024			2023
Total operating income for reportable segment (1)	$	19,069,000		$	9,993,000		$	23,893,000		$	36,702,000
Other operating loss		(1,515,000	)		(473,000	)		(322,000	)		(2,852,000	)
Elimination of intersegment operating income		27,000			4,000			74,000			52,000
Interest expense, net		(14,435,000	)		(18,297,000	)		(43,004,000	)		(45,400,000	)
Change in fair value of compound net derivative liability		260,000			(1,160,000	)		2,460,000			(1,690,000	)
Loss on extinguishment of debt		-			-			-			(168,000	)
Total consolidated income (loss) before income tax expense	$	3,406,000		$	(9,933,000	)	$	(16,899,000	)	$	(13,356,000	)

Assets	December 31, 2024			March 31, 2024
Total assets for reportable segment	$	962,855,000		$	1,019,811,000
Other assets		54,855,000			54,946,000
Elimination of intersegment assets		(68,202,000	)		(62,755,000	)
Total consolidated assets	$	949,508,000		$	1,012,002,000

(1)

~~Operating~~Net ~~income~~sales, ~~for~~operating ~~the~~income ~~Company’s~~(loss), ~~Hard~~depreciation ~~Parts~~and ~~segment~~amortization, ~~includes~~capital ~~the~~expenditures, ~~foreign~~and ~~exchange~~assets ~~impact~~from ofsegments ~~lease~~below ~~liabilities~~the ~~and~~quantitative ~~forward~~threshold ~~contracts,~~are ~~which~~attributable ~~were~~to athe ~~loss~~Company’s ofTest ~~$2,460,000~~Solutions and aDiagnostic ~~gain~~Equipment ofand ~~$3,149,000 for~~ the ~~three~~Heavy ~~months~~Duty ~~ended~~operating ~~December~~segments. ~~31,~~Neither ~~2024~~of ~~and~~these ~~2023,~~two ~~respectively,~~operating ~~and~~segments ahas ~~loss~~ever ofmet ~~$18,966,000~~any ~~and a gain~~ of ~~$2,659,000, for~~ the ~~nine~~quantitative ~~months~~thresholds ~~ended~~for ~~December~~determining ~~31,~~reportable ~~2024 and 2023, respectively~~segments.

(2)

The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM for the Company’s Hard Parts reportable segment. Intersegment expenses are included within the amounts shown.

(3)

Logistic expenses include freight, tariffs, and customs duties.

(4)

Other segment items include general and administrative expenses, sales and marketing expenses, and research and development expenses.

(5)

Depreciation and amortization for the Company’s Hard Parts reportable segment are included within material, labor, and overhead expenses and other segment items.

19. Share Repurchases

In August 2018, the Company’s board of directors approved an increase in its share repurchase program from $20,000,000 to $37,000,000 of its common stock. During the three ~~and nine~~ months ended ~~December~~June 3130, ~~2024~~2025, the Company repurchased ~~268~~197,~~130~~796 shares of its common stock for $21,~~096~~966,000. ~~The Company did not repurchase any shares of its common stock during the three and nine months ended December 31, 2023.~~ As of ~~December~~June 3130, ~~2024~~2025, $2025,~~841~~543,000 has been utilized and $1611,~~159~~457,000 remains available to repurchase shares under the authorized share repurchase program, subject to the limit in the Company’s Credit Facility and Convertible Notes. The Company retired the 1,~~105~~576,~~137~~937 shares repurchased under this program through ~~December~~June 3130, ~~2024~~2025. The Company’s share repurchase program does not obligate it to acquire any specific number of shares and shares may be repurchased in privately negotiated and/or open market transactions.

20. Related Party Transactions

Lease

InThe ~~December 2022, the~~ Company ~~entered~~has ~~into~~ an operating lease for its 35,000 square foot manufacturing, warehouse, and office facility in Ontario, Canada, with a company co-owned by a member of management. The ~~lease, which commenced January 1, 2023, has an initial term of one year with a base rent of approximately $27,000 per month and includes options to renew for up to four years. In November 2023, the~~ Company ~~exercised~~renewed ~~one~~this ofoperating ~~these~~lease ~~options to renew~~ for an additional ~~one-year period. In February 2025, the Company exercised a second extension term for an additional~~ three-year period ~~with a base rent of approximately $30~~,~~000~~ ~~per~~effective ~~month, which took effect on~~ January 1, 2025. The rent expense recorded for ~~the~~this related party lease was $8193,000 and $~~243~~81,000 for the three ~~and nine~~ months ended ~~December~~June 3130, ~~2024~~2025 and ~~2023~~2024, respectively.

Convertible Note and Election of Director

In connection with the issuance and sale of the Company’s Convertible Notes on March 31, 2023 (see Note 7), the Board appointed Douglas Trussler, a co-founder of Bison Capital, to the Board. Mr. Trussler’s compensation is ~~consistent~~different ~~with~~from the ~~Company’s previously disclosed standard~~ compensation ~~practices~~ for other non-employee directors, ~~which~~as ~~are~~ described in the Company’s Definitive Proxy Statement, filed with the SEC on July 2629, ~~2024~~2025.

Item 2. ~~Management’s Discussion and Analysis of Financial Condition and Results of Operations~~

~~The~~ Management’s ~~following~~Discussion ~~discussion~~ and ~~analysis~~Analysis ~~presents factors that Motorcar Parts~~ of ~~America,~~Financial ~~Inc.~~Condition and ~~its~~Results ~~subsidiaries (“our,” “we” or “us”) believe are relevant to an assessment and understanding~~ of our consolidated financial position and results of operations. This financial and business analysis should be read in conjunction with our March 31, 2024 audited consolidated financial statements included in our Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on June 11, 2024, and the 10-K/A for the fiscal year ended March 31, 2024 as filed with the SEC on June 28, 2024.Operations

The following discussion and analysis presents factors that Motorcar Parts of America, Inc. and its subsidiaries (“our,” “we” or “us”) believe are relevant to an assessment and understanding of our consolidated financial position and results of operations. This financial and business analysis should be read in conjunction with our March 31, 2025 audited consolidated financial statements included in our Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on June 9, 2025.

Disclosure Regarding Private Securities Litigation Reform Act of 1995

This report may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to our future performance that involve risks and uncertainties. All statements other than statements of historical fact are forward-looking statements, including, but not limited to, statements about our strategic initiatives, operational plans and objectives, expectations for economic conditions and recovery and future business and financial performance, as well as statements regarding underlying assumptions related thereto. They include, among others, factors related to the timing and implementation of strategic initiatives, the highly competitive nature of our industry, demand for our products and services, complexities in our inventory and supply chain, challenges with transforming and growing our business. Except as required by law, we undertake no obligation to revise or update publicly any forward-looking statements for any reason. Therefore, you should not place undue reliance on those statements. Please refer to “Item 1A. Risk Factors” of our most recent Annual Report on Form 10-K filed with the SEC on June 119, ~~2024~~2025, ~~and the 10-K/A for the fiscal year ended March 31, 2024~~ as ~~filed with the SEC on June 28, 2024, as~~ updated by our subsequent filings with the SEC, for a description of these and other risks and uncertainties that could cause actual results to differ materially from those projected or implied by the forward-looking statements.

Management Overview

With a scalable infrastructure and abundant growth opportunities, we are focused on growing our aftermarket hard parts business in the North American marketplace and growing our leadership position in the test solutions and diagnostic equipment market by providing innovative and intuitive solutions to our customers. Our on-going investments in global infrastructure and human resources ~~during the past few years~~ reflects the significant expansion of manufacturing capacity to support multiple product lines. These investments included (i) a 410,000 square foot distribution center, (ii) two buildings totaling 372,000 square feet for remanufacturing and core sorting of brake calipers, and (iii) the realignment of production at our original 312,000 square foot facility in Mexico. In addition, during the nine months ended December 31, 2024, we ceased manufacturing at our Torrance, California facility, reduced our headcount, and incurred certain transition expenses in connection with our on-going strategy to utilize our global footprint to enhance operating efficiencies and expect to realize future benefit from these cost-saving measures.

Segment Reporting

Our three operating segments are as follows:

●

Heavy Duty, which includes non-discretionary automotive aftermarket replacement hard parts for heavy- duty truck, industrial, marine, and agricultural applications.

Our Hard Parts operating segment meets the criteria of a reportable segment. The Test Solutions and Diagnostic Equipment and Heavy Duty segments are not material, and are not required to be separately reported. See Note 18 of the notes to condensed consolidated financial statements for more information.

~~Our~~Results ~~Hard~~of ~~Parts~~Operations ~~operating~~for ~~segment meets~~ the ~~criteria~~Three ofMonths aEnded ~~reportable~~June ~~segment. The Test Solutions and Diagnostic Equipment and Heavy Duty segments are not material~~30, ~~are~~2025 ~~not required to be separately reported,~~ and ~~are included within the “all other” category. See Note 18 of the notes to condensed consolidated financial statements for more information.~~2024

Results of Operations for the Three Months Ended December 31, 2024 and 2023

The following discussion and analysis should be read together with the financial statements and notes thereto appearing elsewhere herein.

The following summarizes certain key consolidated operating data:

		Three Months EndedDecember 31,
	Three Months Ended
		2024			2023
	June 30,
Cash flow provided by operations		$	34,357,000		$	53,615,000
		2025			2024
Finished goods turnover (annualized) (1)			3.7			3.6
Cash flow provided by (used in) operations	$	10,028,000		$	(20,841,000	)
Finished goods turnover (annualized) (1)		4.2			3.3

(1)

Annualized finished goods turnover for the fiscal quarter is calculated by multiplying cost of goods sold for the quarter by 4 and dividing the result by the average between beginning and ending non-core finished goods inventory values for the fiscal quarter. We believe this provides a useful measure of our ability to turn our inventory into revenues.

Net Sales and Gross Profit

The following summarizes net sales and gross profit:

		Three Months EndedDecember 31,
	Three Months Ended
		2024				2023
	June 30,
Net sales		$	186,176,000			$	171,862,000
		2025				2024
Cost of goods sold			141,294,000				141,819,000
Net sales	$	188,364,000			$	169,887,000
Gross profit			44,882,000				30,043,000
Cost of goods sold		154,447,000				140,713,000
Gross margin			24.1	%			17.5	%
Gross profit		33,917,000				29,174,000
Gross margin		18.0	%			17.2	%

Net Sales. Our consolidated net sales for the three months ended ~~December~~June 3130, ~~2024~~2025 were $~~186~~188,~~176~~364,000, which represents an increase of $1418,~~314~~477,000, or 810.39%, from the three months ended ~~December~~June 3130, ~~2023~~2024 of $~~171~~169,~~862~~887,000. Our sales for the three months ended ~~December~~June 3130, ~~2024~~2025 compared with the three months ended ~~December~~June 3130, ~~2023~~2024 reflect continued strong demand for rotating electrical and brake-related products.

Gross Profit. Our consolidated gross profit was $4433,~~882~~917,000, or 2418.10% of consolidated net sales, for the three months ended ~~December~~June 3130, ~~2024~~2025 compared with $3029,~~043~~174,000, or 17.52% of consolidated net sales, for the three months ended ~~December~~June 3130, ~~2023~~2024. The increase in our gross margin for the three months ended ~~December~~June 3130, ~~2024~~2025 reflects ~~the~~(i) ~~benefit~~increased utilization of our ~~on-going~~facilities, ~~strategy~~(ii) tothe ~~utilize~~benefit from our ~~global~~strategies ~~footprint~~ to enhance operating efficiencies and ~~our~~ cost-saving initiatives, and (iii) changes in product mix. WeThese ~~expect~~increases towere ~~continue~~partially tooffset ~~realize~~by ~~benefits~~$1,426,000 ~~from~~for ~~these~~net ~~initiatives~~tariff costs paid for products sold before price increases were effective.

In addition, our gross margin for the three months ended ~~December~~June 3130, ~~2024~~2025 compared with the three months ended ~~December~~June 3130, ~~2023~~2024 was impacted by (i) continued amortization of core and finished goods premiums paid to customers ~~related to new business~~ of $2,~~664~~847,000 and $2,~~838~~728,000, respectively and (ii) the non-cash quarterly revaluation of cores that are part of the finished goods on the customers’ shelves (which are included in contract assets) to the lower of cost or net realizable value, which resulted in a write-down of $~~758~~1,026,000 and $1394,~~607,~~000, respectively.

Operating Expenses

The following summarizes our consolidated operating expenses:

		Three Months EndedDecember 31,
	Three Months Ended
		2024				2023
	June 30,
General and administrative		$	16,212,000			$	15,198,000
		2025				2024
Sales and marketing			5,621,000				5,931,000
General and administrative	$	12,680,000			$	16,670,000
Research and development			3,008,000				2,539,000
Sales and marketing		6,210,000				5,449,000
Foreign exchange impact of lease liabilities and forward contracts			2,460,000				(3,149,000	)
Research and development		3,306,000				2,433,000
Percent of net sales
Foreign exchange impact of lease liabilities and forward contracts		(8,348,000	)			11,078,000
General and administrative			8.7	%			8.8	%
Percent of net sales
Sales and marketing			3.0	%			3.5	%
General and administrative		6.7	%			9.8	%
Research and development			1.6	%			1.5	%
Sales and marketing		3.3	%			3.2	%
Foreign exchange impact of lease liabilities and forward contracts			1.3	%			(1.8	)%
Research and development		1.8	%			1.4	%
Foreign exchange impact of lease liabilities and forward contracts		(4.4	)%			6.5	%

General and Administrative. Our general and administrative expenses for the three months ended ~~December~~June 3130, ~~2024~~2025 were $1612,~~212~~680,000, which represents ana ~~increase~~decrease of $13,~~014~~990,000, or 623.79%, from the three months ended ~~December~~June 3130, ~~2023~~2024 of $1516,~~198~~670,000. This ~~increase~~decrease was primarily due to (i) a ~~loss~~headcount ofreduction in the prior year, which resulted in $12,~~272~~940,000 of severance during the three months ended ~~December~~June 3130, 2024 ~~compared~~and ~~with~~(ii) athe ~~gain~~benefit of ~~$528,000~~favorable ~~during~~fluctuations ~~the~~in ~~three~~foreign ~~months~~currency ~~ended~~exchange ~~December~~rates ~~31,~~on ~~2023~~transactions ~~resulting~~denominated ~~from~~in foreign ~~currency~~currencies ~~exchange~~during ~~rates~~the ~~partially~~current ~~offset~~year bycompared ~~decreased~~with ~~employee-related~~the ~~expenses~~prior year.

Sales and Marketing. Our sales and marketing expenses for the three months ended ~~December~~June 3130, ~~2024~~2025 were $56,~~621~~210,000, which represents aan ~~decrease~~increase of $~~310~~761,000, or 514.20%, from the three months ended ~~December~~June 3130, ~~2023~~2024 of $5,~~931~~449,000. This ~~decrease~~increase was primarily due to ~~lower~~increased ~~trade~~commissions ~~shows~~expense and ~~commissions~~increased ~~expense~~headcount.

Research and Development. Our research and development expenses for the three months ended ~~December~~June 3130, ~~2024~~2025 were $3,~~008~~306,000, which represents an increase of $~~469~~873,000, or 1835.59%, from the three months ended ~~December~~June 3130, ~~2023~~2024 of $2,~~539~~433,000. This increase was primarily due to increased headcount, ~~and~~professional ~~outside~~services, ~~consulting~~and ~~services~~supplies.

Foreign Exchange Impact of Lease Liabilities and Forward Contracts. Our foreign exchange impact of lease liabilities and forward contracts were a non-cash ~~loss~~gain of $28,~~460~~348,000 compared with a non-cash ~~gain~~loss of $311,~~149~~078,000 for the three months ended ~~December~~June 3130, ~~2024~~2025 and ~~2023~~2024, respectively. This change during the three months ended ~~December~~June 3130, ~~2024~~2025 compared with the three months ended ~~December~~June 3130, ~~2023~~2024 was primarily due to (i) the remeasurement of our foreign currency-denominated lease liabilities, which resulted in a non-cash ~~loss~~gain of $14,~~875~~002,000 compared with a non-cash ~~gain~~loss of $25,~~608~~709,000, respectively, due to foreign currency exchange rate fluctuations and (ii) the forward foreign currency exchange contracts, which resulted in a non-cash ~~loss~~gain of $~~585~~4,346,000 compared with a non-cash ~~gain~~loss of $~~541~~5,369,000, respectively, due to the changes in their fair values.

Operating Income (Loss)

Consolidated Operating Income (Loss). Our consolidated operating income for the three months ended ~~December~~June 3130, ~~2024~~2025 was $1720,~~581~~069,000 compared with a consolidated operating loss of $96,~~524~~456,000 for the three months ended ~~December~~June 3130, ~~2023~~2024. This increase was primarily due ~~increased~~to ~~gross~~(i) ~~profit partially offset by~~ our foreign exchange impact of lease liabilities and forward contracts, which were a non-cash ~~loss~~gain of $28,~~460~~348,000 compared with a non-cash ~~gain~~loss of $311,~~149~~078,000, ~~for~~(ii) ~~the~~increased ~~three~~gross ~~months~~profit, ~~ended~~(iii) ~~December~~decreased ~~31,~~general ~~2024~~ and ~~2023~~administrative expenses, ~~respectively~~ and (iv) other items as discussed above.

Interest Expense

Interest Expense, net. Our interest expense for the three months ended December 31, 2024 was $14,435,000, which represents a decrease of $3,862,000, or 21.1%, from interest expense for the three months ended December 31, 2023 of $18,297,000. This decrease was primarily due to (i) decreased utilization of accounts receivable discount programs and lower discount rates on those programs and (ii) lower average outstanding balances under our credit facility and lower interest rates.

Change in Fair Value of Compound Net Derivative Liability

Change in Fair Value of Compound Net Derivative Liability. Our change in fair value of compound net derivative liability associated with the convertible notes issued on March 31, 2023 was a non-cash gain of $260,000 compared with a non-cash loss of $1,160,000 for the three months ended December 31, 2024 and 2023, respectively.

Provision for Income Taxes

Income Tax. We recorded an income tax expense of $1,115,000, or an effective tax rate of 32.7%, and $37,281,000 or an effective tax rate of (375.3)%, for the three months ended December 31, 2024 and 2023, respectively. The effective tax rate for the three months ended December 31, 2024, was primarily impacted by (i) the change in valuation allowance, (ii) specific jurisdictions that we do not expect to recognize the benefit of losses, and (iii) foreign income taxed at rates that are different from the federal statutory rate. Our effective tax rate for the three months ended December 31, 2023 was primarily impacted by the establishment of a valuation allowance on deferred tax assets that were not expected to be realized.

Results of Operations for the Nine Months Ended December 31, 2024 and 2023

The following discussion and analysis should be read together with the financial statements and notes thereto appearing elsewhere herein.

The following summarizes certain key consolidated operating data:

	Nine Months EndedDecember 31,
	2024		2023
Cash flows provided by operations	$	36,368,000	$	48,445,000
Finished goods turnover (annualized) (1)		3.8		3.7

(1)

Annualized finished goods turnover for the fiscal period is calculated by multiplying cost of goods sold for the fiscal period by 1.33 and dividing the result by the average between beginning and ending non-core finished goods inventory values for the fiscal period. We believe this provides a useful measure of our ability to turn our inventory into revenues.

Net Sales and Gross Profit

The following summarizes net sales and gross profit:

	Nine Months EndedDecember 31,
	2024			2023
Net sales	$	564,249,000		$	528,206,000
Cost of goods sold		448,916,000			430,448,000
Gross profit		115,333,000			97,758,000
Gross margin		20.4	%		18.5	%

Net Sales. Our consolidated net sales for the nine months ended December 31, 2024 were $564,249,000, which represents an increase of $36,043,000, or 6.8%, from the nine months ended December 31, 2023 of $528,206,000. Our sales for the nine months ended December 31, 2024 compared with the nine months ended December 31, 2023 reflect continued strong demand for rotating electrical and brake-related products. In addition, we have experienced strong demand for our test solutions and diagnostic equipment.

Table of Contents

Gross Profit. Our consolidated gross profit was $115,333,000, or 20.4% of consolidated net sales, for the nine months ended December 31, 2024 compared with $97,758,000, or 18.5% of consolidated net sales, for the nine months ended December 31, 2023. The increase in our gross margin for the nine months ended December 31, 2024 reflects the benefit of our on-going strategy to utilize our global footprint to enhance operating efficiencies and our cost-saving initiatives. These increases were partially offset by (i) $3,960,000 of certain one-time expenses for onboarding new business and (ii) $1,298,000 of transition expenses in connection with our on-going strategy to utilize our global footprint to enhance operating efficiencies. We expect to continue to realize benefits from these initiatives.

In addition, our gross margin for the nine months ended December 31, 2024 compared with the nine months ended December 31, 2023 was impacted by (i) amortization of core and finished goods premiums paid to customers related to new business of $8,013,000 and $8,202,000, respectively and (ii) the non-cash quarterly revaluation of cores that are part of the finished goods on the customers’ shelves (which are included in contract assets) to the lower of cost or net realizable value, which resulted in a write-down of $2,316,000 and $4,380,000, respectively.

Operating Expenses

The following summarizes our consolidated operating expenses:

	Nine Months EndedDecember 31,
	2024			2023
General and administrative	$	47,934,000		$	42,125,000
Sales and marketing		16,904,000			17,038,000
Research and development		7,884,000			7,352,000
Foreign exchange impact of lease liabilities and forward contracts		18,966,000			(2,659,000	)
Percent of net sales
General and administrative		8.5	%		8.0	%
Sales and marketing		3.0	%		3.2	%
Research and development		1.4	%		1.4	%
Foreign exchange impact of lease liabilities and forward contracts		3.4	%		(0.5	)%

General and Administrative. Our general and administrative expenses for the nine months ended December 31, 2024 were $47,934,000, which represents an increase of $5,809,000, or 13.8%, from the nine months ended December 31, 2023 of $42,125,000. This increase was primarily due to (i) a loss of $2,998,000 during the nine months ended December 31, 2024 compared with a gain of $683,000 during the nine months ended December 31, 2023 resulting from foreign currency exchange rates and (ii) $2,834,000 of increased severance during the nine months ended December 31, 2024 due to headcount reductions in connection with our strategy to utilize our global footprint to enhance operating efficiencies. These increases were partially offset by $1,259,000 of decreased share-based compensation expense.

Sales and Marketing. Our sales and marketing expenses were consistent at $16,904,000 for the nine months ended December 31, 2024 compared with $17,038,000 for the nine months ended December 31, 2023.

Research and Development. Our research and development expenses for the nine months ended December 31, 2024 were $7,884,000, which represents an increase of $532,000, or 7.2%, from the nine months ended December 31, 2023 of $7,352,000. This increase was primarily due to increased headcount partially offset by decreased supplies.

Table of Contents

Foreign Exchange Impact of Lease Liabilities and Forward Contracts. Our foreign exchange impact of lease liabilities and forward contracts were a non-cash loss of $18,966,000 compared with a non-cash gain of $2,659,000 for the nine months ended December 31, 2024 and 2023, respectively. This change during the nine months ended December 31, 2024 compared with the nine months ended December 31, 2023 was primarily due to (i) the remeasurement of our foreign currency-denominated lease liabilities, which resulted in a non-cash loss of $11,562,000 compared with a non-cash gain of $4,430,000, respectively, due to foreign currency exchange rate fluctuations and (ii) the forward foreign currency exchange contracts, which resulted in non-cash losses of $7,404,000 and $1,771,000, respectively, due to the changes in their fair values.

Operating Income

Consolidated Operating Income. Our consolidated operating income for the nine months ended December 31, 2024 was $23,645,000 compared with $33,902,000 for the nine months ended December 31, 2023. This decrease was primarily due our foreign exchange impact of lease liabilities and forward contracts, which were a non-cash loss of $18,966,000 compared with a non-cash gain of $2,659,000 for the nine months ended December 31, 2024 and 2023, respectively partially offset by higher gross profit and other items as discussed above.

Interest Expense

Interest Expense, net. Our interest expense for the ~~nine~~three months ended ~~December~~June 3130, ~~2024~~2025 was $4312,~~004~~812,000, which represents a decrease of $21,~~396~~575,000, or 510.39%, from interest expense for the ~~nine~~three months ended ~~December~~June 3130, ~~2023~~2024 of $4514,~~400~~387,000. This decrease was primarily due to (i) lower average outstanding balances under our credit facility and (ii) lower interest rates. on both our credit facility and accounts receivable discount programs.

Change in Fair Value of Compound Net Derivative Liability

Change in Fair Value of Compound Net Derivative Liability. Our change in fair value of compound net derivative liability associated with the convertible notes issued on March 31, 2023 was a non-cash ~~gain~~loss of $21,~~460~~790,000 compared with a non-cash ~~loss~~gain of $12,~~690~~580,000 for the ~~nine~~three months ended ~~December~~June 3130, ~~2024~~2025 and ~~2023~~2024, respectively.

Loss on Extinguishment of Debt

Loss on Extinguishment of Debt. Our loss on extinguishment of debt was $168,000 in connection with the repayment of the remaining outstanding balance of our term loans during the nine months ended December 31, 2023.

Provision for Income Taxes

Income Tax. We recorded an income tax expense of $12,~~849~~425,000, or an effective tax rate of ~~(10~~44.9)4%, and income tax benefit of $37178,~~226,~~000, or an effective tax rate of ~~(278~~1.7)0%, for the ~~nine~~three months ended ~~December~~June 3130, ~~2024~~2025 and ~~2023~~2024, respectively. The effective tax rate for the ~~nine~~three months ended ~~December~~June 3130, ~~2024~~2025, was primarily impacted by ~~(i) foreign income taxed at rates that are different from~~ the ~~federal statutory rate, (ii) the~~ change in valuation allowance, on ~~and~~certain ~~(iii) specific~~ jurisdictions' ~~that~~deferred ~~we do not expect to recognize the benefit of losses. Our effective~~ tax ~~rate~~assets ~~for~~resulting ~~the~~from current ~~nine~~year ~~months~~activities ~~ended~~and ~~December~~foreign ~~31,~~income ~~2023~~taxed ~~was~~at ~~primarily~~rates ~~impacted by the establishment of a valuation allowance on deferred tax assets~~ that ~~were~~are ~~not~~different ~~expected~~from tothe befederal ~~realized~~statutory rate.

Liquidity and Capital Resources

Overview

We had working capital (current assets minus current liabilities) of $~~155~~158,~~693~~766,000 and $~~156~~160,~~034~~446,000, a ratio of current assets to current liabilities of 1.4:1.0, at ~~December~~June 3130, ~~2024~~2025 and 1.5:1.0 at March 31, ~~2024, respectively~~2025.

InOur ~~June~~primary ~~2024,~~source weof ~~enrolled~~liquidity inwas afrom ~~feature~~cash ~~with~~generated from operations, the use of our ~~lenders~~receivable discount programs, ~~under~~and ~~which~~credit wefacility ~~sweep~~during the three months ended June 30, 2025. We believe our cash ~~collections~~and tocash ~~pay~~equivalents, ~~down~~use ~~our~~of ~~revolving~~receivable ~~facility~~discount programs, and ~~borrow~~amounts ~~on-demand~~available tounder ~~fund~~our ~~payments.~~credit ~~This~~facility ~~feature~~are issufficient to satisfy our expected tofuture ~~reduce~~liquidity ~~interest~~needs, ~~expense~~including onlease ~~borrowings~~and ~~under~~capital expenditure obligations over the ~~credit~~next ~~facility~~12 months.

Our primary source of liquidity was from cash generated from operations, the use of our receivable discount programs, and credit facility during the nine months ended December 31, 2024. We believe our cash and cash equivalents, use of receivable discount programs, amounts available under our credit facility, and other sources are sufficient to satisfy our expected future liquidity needs, including lease and capital expenditure obligations over the next 12 months.

Table of Contents

Share Repurchase Program

In August 2018, our board of directors approved an increase in our share repurchase program from $20,000,000 to $37,000,000 of our common stock. During the three ~~and nine~~ months ended ~~December~~June 3130, ~~2024~~2025, we repurchased ~~268~~197,~~130~~796 shares of our common stock for $21,~~096~~996,000. ~~We did not repurchase any shares of our common stock during the three and nine months ended December 31, 2023.~~ As of ~~December~~June 3130, ~~2024~~2025, $2025,~~841~~543,000 has been utilized and $1611,~~159~~457,000 remains available to repurchase shares under the authorized share repurchase program, subject to the limit in our ~~Credit~~credit ~~Facility~~facility and convertible notes. We retired the 1,~~105~~576,~~137~~937 shares repurchased under this program through ~~December~~June 3130, ~~2024~~2025. Our share repurchase program does not obligate us to acquire any specific number of shares and shares may be repurchased in privately negotiated and/or open market transactions.

Cash Flows

The following summarizes cash flows as reflected in the condensed consolidated statements of cash flows:

		Nine Months EndedDecember 31,
	Three Months Ended
		2024				2023
	June 30,
Cash flows provided by (used in):
		2025				2024
Operating activities		$	36,368,000			$	48,445,000
Cash flows provided by (used in):
Investing activities			(1,614,000	)			(420,000	)
Operating activities	$	10,028,000			$	(20,841,000	)
Financing activities			(36,796,000	)			(47,646,000	)
Investing activities		(806,000	)			(512,000	)
Effect of exchange rates on cash and cash equivalents			(1,122,000	)			180,000
Financing activities		(6,778,000	)			15,166,000
Net (decrease) increase in cash and cash equivalents		$	(3,164,000	)		$	559,000
Effect of exchange rates on cash and cash equivalents		606,000				(256,000	)
Additional selected cash flow data:
Net increase (decrease) in cash and cash equivalents	$	3,050,000			$	(6,443,000	)
Depreciation and amortization		$	7,862,000			$	8,844,000
Additional selected cash flow data:
Capital expenditures			1,716,000				462,000
Depreciation and amortization	$	2,449,000			$	2,729,000
Capital expenditures		807,000				490,000

Net cash provided by operating activities was $3610,~~368~~028,000 ~~and~~compared with net cash used in operating activities of $4820,~~445~~841,000 during the ~~nine~~three months ended ~~December~~June 3130, ~~2024~~2025 and ~~2023~~2024, respectively. The changes in our operating activities were primarily ~~impacted~~due byto (i) ~~the~~an ~~pay~~increase ~~down~~in of our accounts payable ~~balances,~~during ~~(ii)~~the athree ~~less~~months ~~significant~~ended ~~decrease~~June in30, ~~accounts~~2025 ~~receivable~~to ~~balances~~support ~~compared with~~ the ~~prior~~build-up ~~year,~~of ~~and~~our ~~(iii)~~inventory ~~an increase~~ in ~~cores~~anticipation ~~that are part~~ of ~~the finished goods on the customers’ shelves (which are included in contract assets) due to~~ higher sales compared with ~~the~~a ~~prior~~decrease ~~year. These decreases were partially offset by inventory reduction initiatives~~ in ~~the~~our ~~current~~accounts ~~year~~payable ~~compared~~during ~~with~~ the ~~investment~~three inmonths ~~inventory~~ended inJune ~~the~~30, ~~prior~~2024 ~~year~~ and by(ii) increased operating results (net income plus the net add-back for non-cash transactions in earnings). We continue to manage our working capital to maximize our operating cash flow.

Net cash used in investing activities was $1806,~~614,~~000 and $~~420~~512,000 during the ~~nine~~three months ended ~~December~~June 3130, ~~2024~~2025 and ~~2023~~2024, respectively. The change in our investing activities primarily resulted from increased capital expenditures.

Net cash used in financing activities was $366,~~796~~778,000 ~~and~~compared with net cash provided by financing activities of $4715,~~646~~166,000 during the ~~nine~~three months ended ~~December~~June 3130, ~~2024~~2025 and ~~2023~~2024, respectively. The change in our financing activities were primarily ~~resulted~~due ~~from~~to (i) the ~~repayment~~net repayments of amounts outstanding under our ~~term~~revolving ~~loans~~facility induring the ~~prior~~three ~~year~~months ended June 30, 2025 compared with net borrowing during the three months ended June 30, 2024 and (ii) the repurchase of 197,796 shares of our common stock for $1,966,000 during the three months ended June 30, 2025.

Table of Contents

Capital Resources

Credit Facility

We have $268,620,000 in senior secured financing (as amended from time to time, the “Credit Facility”) consisting of a $238,620,000 revolving loan facility (the “Revolving Facility”), subject to certain restrictions, and a $30,000,000 term loan facility (the “Term Loans”). The Term Loans were repaid during the year ended March 31, 2024. The Credit Facility matures on December 12, 2028. The lenders have a security interest in substantially all of our assets. In June 2024, we enrolled in a feature with our lenders, under which we sweep our cash collections to pay down our revolving facility and borrow on-demand to fund payments. This feature is expected to reduce interest expense on borrowings under the Credit Facility.

We had $9486,~~802~~856,000 and $~~128~~90,~~000~~787,000 outstanding under the Revolving Facility at ~~December~~June 3130, ~~2024~~2025 and March 31, ~~2024~~2025, respectively. In addition, $711,~~047~~888,000 was outstanding for letters of credit at ~~December~~June 3130, ~~2024~~2025. At ~~December~~June 3130, ~~2024~~2025, after certain contractual adjustments, $~~127~~134,~~962~~341,000 was available under the Revolving Facility. The interest rate on our Revolving Facility was 7.6640% and 87.4346%, at ~~December~~June 3130, ~~2024~~2025 and March 31, ~~2024~~2025, respectively.

The Credit Facility requires us to maintain a minimum fixed charge coverage ratio if undrawn availability is less than 22.5% of the aggregate revolving commitments and a specified minimum undrawn availability. During the ~~nine~~three months ended ~~December~~June 3130, ~~2024~~2025, undrawn availability was greater than the 22.5% threshold, therefore, the fixed charge coverage ratio financial covenant was not required to be tested.

~~Convertible Notes~~ 30

On March 31, 2023, we entered into a note purchase agreement, as amended, (the “Note Purchase Agreement”) with Bison Capital Partners VI, L.P. and Bison Capital Partners VI-A, L.P. (collectively, the “Purchasers”) and Bison Capital Partners VI, L.P., as the purchaser representative (the “Purchaser Representative”) for the issuance and sale of $32,000,000 in aggregate principal amount of convertible notes due in 2029 (the “Convertible Notes”), which was used for general corporate purposes. The Convertible Notes bear interest at a rate of 10.0% per annum, compounded annually, and payable (i) in-kind or (ii) in cash, annually in arrears on April 1 of each year, commencing on April 1, 2024. In April 2024, non-cash accrued interest on the Convertible Notes of $3,209,000 was paid in-kind and is included in the principal amount of Convertible Notes at December 31, 2024. The Convertible Notes have an initial conversion price of approximately $15.00 per share of common stock. (“Conversion Option”). Unless and until we deliver a redemption notice, the Purchasers of the Convertible Notes may convert their Convertible Notes at any time at their option. Upon conversion, the Convertible Notes will be settled in shares of our common stock. Except in the case of the occurrence of a fundamental transaction, as defined in the form of convertible promissory note, we may not redeem the Convertible Notes prior to March 31, 2026. After March 31, 2026, we may redeem all or part of the Convertible Notes for a cash purchase (the “Company Redemption”) price. The effective interest rate was 18.3% as of December 31, 2024 and March 31, 2024, respectively.

In connection with the Note Purchase Agreement, we entered into common stock warrants (the “Warrants”) with the Purchasers, which mature on March 30, 2029. The fair value of the Warrants, using Level 3 inputs and the Monte Carlo simulation model, was zero at December 31, 2024 and March 31, 2024.

The Company Redemption option has been combined with the Conversion Option as a compound net derivative liability (the “Compound Net Derivative Liability”). The Compound Net Derivative Liability has been recorded within convertible note, related party in the condensed consolidated balance sheets at December 31, 2024 and March 31, 2024. The fair value of the Conversion Option and the Company Redemption option using Level 3 inputs and the Monte Carlo simulation model was a liability of $5,600,000 and $9,800,000, and an asset of $650,000 and $2,390,000 at December 31, 2024 and March 31, 2024, respectively. During the three months ended December 31, 2024 and 2023, we recorded a gain of $260,000 and a loss of $1,160,000, respectively, as the change in fair value of the Compound Net Derivative Liability in the condensed consolidated statements of operations. During the nine months ended December 31, 2024 and 2023, we recorded a gain of $2,460,000 and a loss of $1,690,000, respectively, as the change in fair value of the Compound Net Derivative Liability in the condensed consolidated statements of operations and condensed consolidated statements of cash flows.

Table of Contents

Convertible Notes

On March 31, 2023, we entered into a note purchase agreement, as amended, (the “Note Purchase Agreement”) with Bison Capital Partners VI, L.P. and Bison Capital Partners VI-A, L.P. (collectively, the “Purchasers”) and Bison Capital Partners VI, L.P., as the purchaser representative (the “Purchaser Representative”) for the issuance and sale of $32,000,000 in aggregate principal amount of convertible notes due in 2029 (the “Convertible Notes”), which was used for general corporate purposes. The Convertible Notes bear interest at a rate of 10.0% per annum, compounded annually, and payable (i) in-kind or (ii) in cash, annually in arrears on April 1 of each year, commencing on April 1, 2024. In April 2025, non-cash accrued interest on the Convertible Notes of $3,521,000 was paid in-kind and is included in the principal amount of Convertible Notes at June 30, 2025. The Convertible Notes have an initial conversion price of $15.00 per share of the Company's common stock, subject to adjustment as provided in the Convertible Notes (“Conversion Option”). Unless and until we deliver a redemption notice, the Purchasers of the Convertible Notes may convert their Convertible Notes at any time at their option. Upon conversion, the Convertible Notes will be settled in shares of our common stock. Except in the case of the occurrence of a fundamental transaction, as defined in the form of convertible promissory note, we may not redeem the Convertible Notes prior to March 31, 2026. After March 31, 2026, we may redeem all or part of the Convertible Notes for a cash purchase (the “Company Redemption”) price. The effective interest rate was 18.3% as of June 30, 2025 and March 31, 2025, respectively.

Accounts Receivable Discount Programs

We use accounts receivable discount programs offered by certain customers and their respective banks. Under these programs, we have options to sell those customers’ receivables to those banks at a discount to be agreed upon at the time the receivables are sold. These discount arrangements allow us to accelerate receipt of payment on customers’ receivables. While these arrangements have reduced our working capital needs, there can be no assurance that these programs will continue in the future. Interest expense resulting from these programs would increase if interest rates rise, if utilization of these discounting arrangements expands, if customers extend their payment to us, or if the discount period is extended to reflect more favorable payment terms to customers.

The following is a summary of the accounts receivable discount programs:

		Nine Months EndedDecember 31,
	Three Months Ended
		2024				2023
	June 30,
Receivables discounted		$	488,505,000			$	465,073,000
		2025				2024
Weighted average number of days collection was accelerated			342				334
Receivables discounted	$	168,194,000			$	144,541,000
Annualized weighted average discount rate			6.3	%			6.8	%
Weighted average number of days collection was accelerated		345				342
Amount of discount recognized as interest expense		$	29,202,000			$	29,395,000
Annualized weighted average discount rate		5.7	%			6.9	%
Amount of discount recognized as interest expense	$	9,158,000			$	9,507,000

Supplier Finance Programs

We utilize a supplier finance program, which allows certain of our suppliers to sell their receivables due from us to participating financial institutions at the sole discretion of both the supplier and the financial institutions. The program is administered by a third party. Commitments from participating financial institutions that are available to suppliers under this program ~~increased~~were to $2730,000,000 ~~from~~at ~~$15~~June 30,~~000,000~~ ~~during~~2025 ~~the~~and ~~three~~March ~~months ended December~~ 31, ~~2024~~2025. We have no economic interest in the sale of these receivables and no direct relationship with the financial institution. Payments to the third-party administrator are based on services rendered and are not related to the volume or number of financing agreements between suppliers, financial institution, and the third-party administrator. We are not a party to agreements negotiated between participating suppliers and the financial institution. Our obligations to our suppliers, including amounts due and payment terms, are not affected by a supplier's decision to participate in this program. We do not provide guarantees and there are no assets pledged to the financial institution or the third-party administrator for the committed payment in connection with this program. At ~~December~~June 30, 2025 and March 31, ~~2024~~2025, we had $31,~~809~~292,000 and $33,661,000, respectively, of outstanding supplier obligations confirmed as valid under this program, included in accounts payable in the condensed consolidated balance ~~sheet~~sheets.

Capital Expenditures and Commitments

Capital Expenditures

Our total capital expenditures were $2,~~531~~708,000 and $~~559~~493,000 for ~~nine~~three months ended ~~December~~June 3130, ~~2024~~2025 and ~~2023~~2024, respectively. These capital expenditures include (i) cash paid for the purchase of plant and equipment ~~plant~~, (ii) plant and equipment acquired under finance leases, and (iii) non-cash capital expenditures. Capital expenditures for ~~fiscal~~the three months ended June 30, 2025 primarily include the purchase of equipment for our current operations and our global growth initiatives. We expect to incur approximately $58,000,000 of capital expenditures primarily to support our global growth initiatives and ~~current~~maintenance ~~operations~~of our facilities and equipment during fiscal ~~2025~~2026. We have used and expect to continue using our working capital and additional capital lease obligations to finance these capital expenditures.

Related Party Transactions

Lease

InWe ~~December~~have ~~2022, we entered into~~ an operating lease for our 35,000 square foot manufacturing, warehouse, and office facility in Ontario, Canada, with a company co-owned by a member of management. ~~The~~We ~~lease,~~renewed ~~which~~this ~~commenced~~operating ~~January~~lease ~~1, 2023, had an initial term of one year with a base rent of approximately $27,000 per month and included options to renew~~ for ~~up to four years. In November 2023, we exercised one of these options to renew for~~ an additional ~~one-year period. In February 2025, we exercised a second extension term for an additional~~ three-year period ~~with a base rent of approximately $30~~,~~000~~ ~~per~~effective ~~month, which took effect on~~ January 1, 2025. The rent expense recorded for ~~the~~this related party lease was $8193,000 and $~~243~~81,000 for the three ~~and nine~~ months ended ~~December~~June 3130, ~~2024~~2025 and ~~2023~~2024, respectively.

Table of Contents

Convertible Note and Election of Director

In connection with the issuance and sale of our Convertible Notes on March 31, 2023, the Board appointed Douglas Trussler, a co-founder of Bison Capital, to the Board. Mr. Trussler’s compensation is ~~consistent~~different ~~with~~from ~~our~~the ~~previously disclosed standard~~ compensation ~~practices~~ for other non-employee directors, ~~which~~as ~~are~~ described in our Definitive Proxy Statement, filed with the SEC on July 2629, ~~2024~~2025.

Litigation

We are subject to various lawsuits and claims. In addition, government agencies and self-regulatory organizations have the ability to conduct periodic examinations of and administrative proceedings regarding our business, and our compliance with law, code, and regulations related to all matters including but not limited to environmental, information security, taxes, levies, tariffs and such. We have an immaterial amount accrued related to these exposures to various lawsuits, claims, examinations, and ~~claims~~administrative proceedings.

Critical Accounting Policies

There have been no material changes to our critical accounting policies and estimates that are presented in our Annual Report on Form 10-K for the year ended March 31, ~~2024~~2025, which was filed ~~on June 11, 2024, and the 10-K/A for the fiscal year ended March 31, 2024 as filed~~ with the SEC on June 289, ~~2024~~2025.

Accounting Pronouncements Not Yet Adopted

Disclosure Improvements

In October 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2023-06, Disclosure Improvements: Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative. This standard was issued in response to the SEC’s disclosure update and simplification initiative, which affects a variety of topics within the Accounting Standards Codification. The amendments apply to all reporting entities within the scope of the affected Topics unless otherwise indicated. The effective date for each amendment will be the date on which the SEC’s removal of that related disclosure from Regulation S-X or Regulation S-K becomes effective, with early adoption prohibited. We are currently evaluating the impact this guidance will have on our financial statement disclosures.

Reportable Segment Disclosures

In November 2023, the FASB issued ASU 2023-07, Improvements to Reportable Segment Disclosures (Topic 280). This standard requires us to disclose significant segment expenses that are regularly provided to the CODM and are included within each reported measure of segment operating results. The standard also requires us to disclose the total amount of any other items included in segment operating results, which were not deemed to be significant expenses for separate disclosure, along with a qualitative description of the composition of these other items. In addition, the standard also requires disclosure of the CODM’s title and position, as well as detail on how the CODM uses the reported measure of segment operating results to evaluate segment performance and allocate resources. The standard also aligns interim segment reporting disclosure requirements with annual segment reporting disclosure requirements. This guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. We are currently evaluating the impact this guidance will have on our financial statement disclosures.

Table of Contents

Improvements to Income Tax Disclosures

In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures (Topic 740). This standard requires us to provide further disaggregated income tax disclosures for specific categories on the effective tax rate reconciliation, as well as additional information about federal, state/local and foreign income taxes. The standard also requires us to annually disclose our income taxes paid (net of refunds received), disaggregated by jurisdiction. This guidance is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The standard is to be applied prospective basis, although optional retrospective application is permitted. We are currently evaluating the impact this guidance will have on our financial statement disclosures.

Disaggregation of Income Statement Expenses

In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses (“DISE”) (Subtopic 220-40). This standard requires us to disclose, in the footnotes at each interim and annual reporting period, information about expenses by the nature of the expense in addition to certain disclosures about selling expenses. Entities are required to include the following relevant expense captions: (i) purchase of inventory, (ii) employee compensation, (iii) depreciation, (iv) intangible asset amortization, and (v) depreciation, depletion and amortization recognized as part of oil and gas producing activities. ~~This~~In January 2025, the FASB issued ASU No. 2025-01, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40) Clarifying the Effective Date, which is intended to clarify the effective date of ASU No. 2024-03. As clarified in ASU 2025-01, the new guidance is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027, ~~on a prospective basis~~ with ~~the~~early ~~option for retrospective application. Early~~ adoption is permitted. We are currently evaluating the impact this guidance will have on our financial statement disclosures.

Debt with Conversion and Other Options

In November 2024, the FASB issued ASU 2024-04, Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments, which seeks to clarify the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as an induced conversion. This guidance is effective for annual periods beginning after December 15, 2025, including interim periods within those fiscal years., ~~Early~~with early adoption is permitted. We are currently evaluating the impact this guidance will have on our consolidated financial statements and disclosures.

~~Item 3. Quantitative and Qualitative Disclosures About Market Risk~~ 33

Item 43. ~~Controls and Procedures~~

Quantitative and Qualitative Disclosures About Market Risk

There have been no material changes in market risk from the information provided in Item 7A. “Quantitative and Qualitative Disclosures About Market Risk” in our Annual Report on Form 10-K as of March 31, 2025, which was filed with the SEC on June 9, 2025.

Item 4.

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We have established disclosure controls and procedures designed to ensure that the information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms and that such information is accumulated and communicated to management, including our chief executive officer, chief financial officer, and chief accounting officer, as appropriate to allow timely decisions regarding required disclosures.

Under the supervision and with the participation of management, including our chief executive officer, chief financial officer, and chief accounting officer, we have conducted an evaluation of the effectiveness of our disclosure controls and procedures as defined in Exchange Act Rules 13a-15(e) and 15d-15(e). Based on this evaluation, our chief executive officer, chief financial officer, and chief accounting officer concluded that MPA’s disclosure controls and procedures were effective as of ~~December~~June 3130, ~~2024~~2025.

Inherent Limitations on Effectiveness of Controls

The Company’s management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Exchange Act Rules 13a-15(f) and 15d-15(f).

Table of Contents

Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America, applying certain estimates and judgments as required.

Internal control over financial reporting includes those policies and procedures that:

1. Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company;

2. Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and

3. Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Changes in Internal Control Over Financial Reporting

There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) that occurred during the three months ended ~~December~~June 3130, ~~2024~~2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

3735

PART II — OTHER INFORMATION

Item 1. ~~Legal Proceedings~~

We Legal are subject to various lawsuits and claims. In addition, government agencies and self-regulatory organizations have the ability to conduct periodic examinations of and administrative proceedings regarding our business, and our compliance with law, code, and regulations related to all matters including but not limited to environmental, information security, taxes, levies, tariffs and such. We have an immaterial amount accrued related to these exposures to various lawsuits and claims.Proceedings

~~Item~~We 1Aare subject to various lawsuits and claims. ~~Risk~~In ~~Factors~~addition, government agencies and self-regulatory organizations have the ability to conduct periodic examinations of and administrative proceedings regarding our business, and our compliance with law, code, and regulations related to all matters including but not limited to environmental, information security, taxes, levies, tariffs and such. We have an immaterial amount accrued related to these exposures to various lawsuits, claims, examinations, and administrative proceedings.

~~There have been no material changes in, except as noted below, the risk factors set forth in~~ Item 1A to Part I of our Annual Report on Form 10-K for the fiscal year ended March 31, 2024, filed on June 11, 2024, and the 10-K/A for the fiscal year ended March 31, 2024 as filed with the SEC on June 28, 2024.

~~Tariffs imposed by the United~~ ~~States~~ Risk ~~government could have a material adverse effect on our results of~~Factors ~~operations.~~

~~The~~ ~~U.S.~~ There ~~government~~have ~~has~~been ~~placed~~no ~~tariffs~~material onchanges ~~certain~~in ~~goods~~the ~~imported~~risk ~~from~~factors ~~China~~set ~~and other~~forth ~~countries~~in ~~and~~Item ~~may~~1A ~~impose~~to ~~new~~Part ~~tariffs~~I onof ~~goods~~our ~~imported~~Annual ~~from~~Report ~~China~~on ~~and other~~Form ~~countries,~~10-K ~~including~~for ~~products~~the ~~that~~fiscal weyear ~~import.~~ended InMarch ~~retaliation~~31, ~~China~~2025 ~~and other~~as ~~countries~~filed ~~responded~~with ~~by imposing tariffs on a wide range of products imported from~~ the ~~U.S.~~SEC ~~and by adjusting the value of its currency. The U.S government has recently imposed new tariffs~~ on ~~additional~~June ~~countries~~9, ~~including Mexico and Canada from which we remanufacture and distribute products, and we have operations~~2025. ~~Such tariffs could significantly increase the cost of the products~~ ~~that we import and may materially impact our cost of goods and business.~~

If ~~renegotiations~~ Item ~~of existing tariffs are unsuccessful or additional tariffs or trade restrictions are implemented by the U~~2.~~S. or other countries in connection~~ with a global trade war, the resulting escalation of trade tensions could have a material adverse effect on world trade and the global economy. Even in the absence of further tariffs or trade restrictions, the related uncertainty and the market's fear of an economic slowdown could lead to a decrease in consumer spending, and we may experience lower net sales than expected. Reduced net sales may result in reduced operating cash flows if we are not able to appropriately manage inventory levels or leverage expenses.

~~Item 2.~~ Unregistered Sales of Equity Securities and Use of Proceeds

Limitation on Payment of Dividends and Share Repurchases

The Credit Facility currently permits the payment of up to $3027,~~000~~584,000 of dividends and share repurchases for fiscal year ~~2025~~2026, subject to pro forma compliance with amended financial covenants.

Purchases of Equity Securities by the Issuer

Shares repurchased during the three months ended ~~December~~June 3130, ~~2024~~2025 were as follows:

Periods	Total Number of Shares Purchased			Average Price Paid Per Share			Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs			Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs (1)
October 1 - October 31, 2024:
April 1 - April 30, 2025:
Open market and privately negotiated purchases	-	-	$	$-	-	$	-	-	$	$13,423,000	~~18,255,000~~
November 1 - November 30, 2024:
May 1 - May 31, 2025:
Open market and privately negotiated purchases	98,671	~~26,247~~	$	$9.73	~~6.90~~		960,000	~~181,000~~		12,463,000	~~18,074,000~~
December 1 - December 31, 2024:
June 1 - June 30, 2025:
Open market and privately negotiated purchases	99,125	~~241,883~~	$	$10.15	~~7.92~~		1,006,000	~~1,915,000~~		11,457,000	~~16,159,000~~
Total	197,796	~~268,130~~				$	1,966,000	~~2,096,000~~	$	$11,457,000	~~16,159,000~~

(1)

As of ~~December~~June 3130, ~~2024~~2025, $2025,~~841~~543,000 has been utilized and $1611,~~159~~457,000 remains available to repurchase shares under the authorized share repurchase program, subject to the limit in our Credit Facility and Convertible Notes. We retired the 1,~~105~~576,~~137~~937 shares repurchased under this program through ~~December~~June 3130, ~~2024~~2025. Our share repurchase program does not obligate us to acquire any specific number of shares and shares may be repurchased in privately negotiated and/or open market transactions.

Item 3. ~~Defaults Upon Senior Securities~~

Defaults Upon Senior Securities

None.

~~Item 5. Other Information~~ 36

Item 65. ~~Exhibits~~

Other Information

(a)

None.

(b)

None.

(c)

During the quarter ended June 30, 2025, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” as each such term is defined in Item 408 of Regulation S-K.

During the quarter ended June 30, 2025, the Company purchased 197,796 shares under Rule 10b5-1 trading arrangement. The adoption of a 10b5-1 trading arrangement allows the Company the ability to repurchase shares when it would be ordinarily restricted from purchases due to blackout periods or being in possession of material non-public information.

Item 6.

Exhibits

(a)

Exhibits:

Number	Description of Exhibit	~~Description~~Method of ~~Exhibit~~Filing	~~Method of Filing~~
3.1	Certificate of Incorporation of the Company	~~Certificate~~Incorporated ofby ~~Incorporation~~reference ofto Exhibit 3.1 to the Company’s Registration Statement on Form SB-2 declared effective on March 22, 1994 (the “1994 Registration Statement”).	~~Incorporated by reference to Exhibit 3.1 to the Company’s Registration Statement on Form SB-2 declared effective on March 22, 1994 (the “1994 Registration Statement”).~~
3.2	Amendment to Certificate of Incorporation of the Company	~~Amendment~~Incorporated toby ~~Certificate~~reference ofto ~~Incorporation~~Exhibit of3.2 to the Company’s Registration Statement on Form S-1 (No. 33-97498) declared effective on November 14, 1995.	~~Incorporated by reference to Exhibit 3.2 to the Company’s Registration Statement on Form S-1 (No. 33-97498) declared effective on November 14, 1995.~~
3.3	Amendment to Certificate of Incorporation of the Company	~~Amendment~~Incorporated toby ~~Certificate~~reference ofto ~~Incorporation~~Exhibit of3.3 to the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 1997.	~~Incorporated by reference to Exhibit 3.3 to the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 1997.~~
3.4	Amendment to Certificate of Incorporation of the Company	~~Amendment~~Incorporated toby ~~Certificate~~reference ofto ~~Incorporation~~Exhibit of3.4 to the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 1998 (the “1998 Form 10-K”).	~~Incorporated by reference to Exhibit 3.4 to the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 1998 (the “1998 Form 10-K”).~~
3.5	Amendment to Certificate of Incorporation of the Company	~~Amendment~~Incorporated toby ~~Certificate~~reference ofto ~~Incorporation~~Exhibit ofC to the Company’s proxy statement on Schedule 14A filed with the SEC on November 25, 2003.	~~Incorporated by reference to Exhibit C to the Company’s proxy statement on Schedule 14A filed with the SEC on November 25, 2003.~~
3.6	Amended and Restated By-Laws of Motorcar Parts of America, Inc.	~~Amended~~Incorporated ~~and~~by ~~Restated~~reference ~~By-Laws~~to ofExhibit ~~Motorcar~~3.1 ~~Parts~~to ofCurrent ~~America~~Report on Form 8-K filed on August 24, ~~Inc~~2010.	~~Incorporated by reference to Exhibit 3.1 to Current Report on Form 8-K filed on August 24, 2010.~~
3.7	Certificate of Amendment of the Certificate of Incorporation of the Company	~~Certificate~~Incorporated ofby ~~Amendment~~reference ofto ~~the~~Exhibit ~~Certificate~~3.1 ofto ~~Incorporation~~Current ofReport ~~the~~on ~~Company~~Form 8-K filed on April 17, 2014.	~~Incorporated by reference to Exhibit 3.1 to Current Report on Form 8-K filed on April 17, 2014.~~
3.8	Amended and Restated By-Laws of Motorcar Parts of America, Inc., as amended on February 4, 2016	~~Amendment~~Incorporated toby ~~the~~reference ~~Amended~~to ~~and~~Exhibit ~~Restated~~3.1 ~~By-Laws~~to ofCurrent ~~Motorcar~~Report ~~Parts~~on ofForm ~~America,~~8-K ~~Inc.,~~filed ~~as adopted~~ on ~~June~~February 910, 2016.	~~Incorporated by reference to Exhibit 3.1 to Current Report on Form 8-K filed on June 14, 2016.~~
3.9	Amendment to the Amended and Restated By-Laws of Motorcar Parts of America, Inc., as adopted on June 9, 2016	~~Amendment~~Incorporated by reference to ~~the~~Exhibit ~~Amended~~3.1 ~~and~~to ~~Restated~~Current ByReport on Form 8-~~Laws~~K offiled ~~the~~on ~~Company~~June 14, 2016.	~~Incorporated by reference to Exhibit 3.1 to Current Report on Form 8-K filed on February 22, 2017.~~
3.10	Amendment to the Amended and Restated By-Laws of the Company	~~Third~~Incorporated ~~Amendment~~by reference to ~~the~~Exhibit ~~Amended~~3.1 ~~and~~to ~~Restated~~Current ~~By-Laws~~Report ofon ~~Motorcar~~Form ~~Parts~~8-K offiled ~~America, Inc., as adopted~~ on ~~January~~February 2622, ~~2022~~2017.	~~Incorporated by reference to Exhibit 3.1 to Current Report on Form 8-K filed on February 1, 2022.~~
4.1		Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934	Incorporated by reference to Exhibit 4.1 to Quarterly Report on Form 10-Q filed on August 9, 2022
3.11	Third Amendment to the Amended and Restated By-Laws of Motorcar Parts of America, Inc., as adopted on January 26, 2022	Incorporated by reference to Exhibit 3.1 to Current Report on Form 8-K filed on February 1, 2022.
4.2		2010 Incentive Award Plan	Incorporated by reference to Appendix A to the Proxy Statement on Schedule 14A filed on December 15, 2010.
4.1	Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934	Incorporated by reference to Exhibit 4.1 to Quarterly Report on Form 10-Q filed on August 9, 2022.
4.3		Amended and Restated 2010 Incentive Award Plan	Incorporated by reference to Appendix A to the Proxy Statement on Schedule 14A filed on March 5, 2013.
4.2	2010 Incentive Award Plan	Incorporated by reference to Appendix A to the Proxy Statement on Schedule 14A filed on December 15, 2010.


Number	Description of Exhibit	Method of Filing
4.3	Amended and Restated 2010 Incentive Award Plan	Incorporated by reference to Appendix A to the Proxy Statement on Schedule 14A filed on March 5, 2013.
4.4	Second Amended and Restated 2010 Incentive Award Plan	Incorporated by reference to Appendix A to the Proxy Statement on Schedule 14A filed on March 3, 2014.
4.5	Third Amended and Restated 2010 Incentive Award Plan	Incorporated by reference to Appendix A to the Proxy Statement on Schedule 14A filed on November 20, 2017.
4.6	Fourth Amended and Restated 2010 Incentive Award Plan	Incorporated by reference to Appendix A to the Proxy Statement on Schedule 14A filed on July 24, 2020.
4.7	2022 Incentive Award Plan	Incorporated by reference to Appendix A to the Proxy Statement on Schedule 14A filed on July 29, 2022.
4.8	Form of Convertible Promissory Note	Incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed on March 31, 2023.
4.9	Form of Common Stock Warrant	Incorporated by reference to Exhibit 4.2 to the Current Report on Form 8-K filed on March 31, 2023.
4.10	First Amended and Restated Convertible Promissory Note	Incorporated by reference to Exhibit 4.12 to the Annual Report on Form 10-K filed on June 14, 2023.
4.11	First Amended and Restated Common Stock Warrant	Incorporated by reference to Exhibit 4.13 to the Annual Report on Form 10-K filed on June 14, 2023.
4.12	First Amended and Restated 2022 Incentive Award Plan	Incorporated by reference to Appendix B to the Proxy Statement on Schedule 14A filed on July 26, 2024.
10.1	Policy for Recovery of Erroneously Awarded Compensation	Filed herewith.
31.1	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes Oxley Act of 2002	Filed herewith.
31.2	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes Oxley Act of 2002	Filed herewith.
31.3	Certification of Chief Accounting Officer pursuant to Section 302 of the Sarbanes Oxley Act of 2002	Filed herewith.
32.1	Certifications of Chief Executive Officer, Chief Financial Officer and Chief Accounting Officer pursuant to Section 906 of the Sarbanes Oxley Act of 2002	Filed herewith.

Number	Description of Exhibit	~~Description~~Method of ~~Exhibit~~Filing	~~Method of Filing~~
4.4		Second Amended and Restated 2010 Incentive Award Plan	Incorporated by reference to Appendix A to the Proxy Statement on Schedule 14A filed on March 3, 2014.
101.INS	Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the inline XBRL document).
4.5		2014 Non-Employee Director Incentive Award Plan	Incorporated by reference to Appendix B to the Proxy Statement on Schedule 14A filed on March 3, 2014.
101.SCM	Inline XBRL Taxonomy Extension Schema Document
4.6		Third Amended and Restated 2010 Incentive Award Plan	Incorporated by reference to Appendix A to the Proxy Statement on Schedule 14A filed on November 20, 2017.
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document
4.7		Fourth Amended and Restated 2010 Incentive Award Plan	Incorporated by reference to Appendix A to the Proxy Statement on Schedule 14A filed on July 24, 2020.
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document
4.8		2022 Incentive Award Plan	Incorporated by reference to Appendix A to the Proxy Statement on Schedule 14A filed on July 29, 2022.
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document
4.9		Form of Convertible Promissory Note	Incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed on March 31, 2023.
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document
4.10		Form of Common Stock Warrant	Incorporated by reference to Exhibit 4.2 to the Current Report on Form 8-K filed on March 31, 2023.
104	Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
4.11		First Amended and Restated Convertible Promissory Note	Incorporated by reference to Exhibit 4.12 to the Annual Report on Form 10-K filed on June 14, 2023.
4.12		First Amended and Restated Common Stock Warrant	Incorporated by reference to Exhibit 4.13 to the Annual Report on Form 10-K filed on June 14, 2023.
4.13		First Amended and Restated 2022 Incentive Award Plan	Incorporated by reference to Appendix B to the Proxy Statement on Schedule 14A filed on July 26, 2024.
31.1		Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes Oxley Act of 2002	Filed herewith.
31.2		Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes Oxley Act of 2002	Filed herewith.
31.3		Certification of Chief Accounting Officer pursuant to Section 302 of the Sarbanes Oxley Act of 2002	Filed herewith.
32.1		Certifications of Chief Executive Officer, Chief Financial Officer and Chief Accounting Officer pursuant to Section 906 of the Sarbanes Oxley Act of 2002	Filed herewith.
97.1		Policy for Recovery of Erroneously Awarded Compensation	Incorporated by reference to Exhibit 97.1 to the Annual Report on Form 10-K/A filed on June 28, 2024.

Number	Description of Exhibit	Method of Filing
101.INS	Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the inline XBRL document)
101.SCM	Inline XBRL Taxonomy Extension Schema Document
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	MOTORCAR PARTS OF AMERICA, INC.
Dated: February 10, 2025	By:	/s/ David Lee
Dated: August 11, 2025	By:	/s/ David Lee
		David Lee
		Chief Financial Officer
Dated: February 10, 2025	By:	/s/ Kamlesh Shah
Dated: August 11, 2025	By:	/s/ Kamlesh Shah
		Kamlesh Shah
		Chief Accounting Officer

42 41

http://fasb.org/us-gaap/2024#RelatedPartyMember http://fasb.org/us-gaap/2024#RelatedPartyMember http://fasb.org/us-gaap/2024#ConvertibleDebtNoncurrent http://fasb.org/us-gaap/2024#ConvertibleDebtNoncurrent http://fasb.org/us-gaap/2024#ConvertibleDebtNoncurrent http://fasb.org/us-gaap/2024#ConvertibleDebtNoncurrent http://fasb.org/us-gaap/2024#OperatingLeaseRightOfUseAsset http://fasb.org/us-gaap/2024#OperatingLeaseRightOfUseAsset http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentNet http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentNet http://fasb.org/us-gaap/2024#OperatingLeaseLiabilityCurrent http://fasb.org/us-gaap/2024#OperatingLeaseLiabilityCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OperatingLeaseLiabilityNoncurrent http://fasb.org/us-gaap/2024#OperatingLeaseLiabilityNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#AccountsPayableAndAccruedLiabilitiesCurrent P1Y P3Y P3Y 0.33 0.33 0.33 P1Y P3Y 0000918251 false 2025 Q3 --03-31 0000918251 2024-04-01 2024-12-31 0000918251 2025-02-03 0000918251 2024-12-31 0000918251 2024-03-31 0000918251 us-gaap:SeriesAPreferredStockMember 2024-12-31 0000918251 us-gaap:SeriesAPreferredStockMember 2024-03-31 0000918251 2024-10-01 2024-12-31 0000918251 2023-10-01 2023-12-31 0000918251 2023-04-01 2023-12-31 0000918251 us-gaap:CommonStockMember 2024-03-31 0000918251 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000918251 us-gaap:RetainedEarningsMember 2024-03-31 0000918251 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0000918251 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0000918251 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0000918251 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0000918251 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0000918251 2024-04-01 2024-06-30 0000918251 us-gaap:CommonStockMember 2024-06-30 0000918251 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0000918251 us-gaap:RetainedEarningsMember 2024-06-30 0000918251 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0000918251 2024-06-30 0000918251 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0000918251 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0000918251 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0000918251 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0000918251 2024-07-01 2024-09-30 0000918251 us-gaap:CommonStockMember 2024-09-30 0000918251 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0000918251 us-gaap:RetainedEarningsMember 2024-09-30 0000918251 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0000918251 2024-09-30 0000918251 us-gaap:CommonStockMember 2024-10-01 2024-12-31 0000918251 us-gaap:AdditionalPaidInCapitalMember 2024-10-01 2024-12-31 0000918251 us-gaap:RetainedEarningsMember 2024-10-01 2024-12-31 0000918251 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-10-01 2024-12-31 0000918251 us-gaap:CommonStockMember 2024-12-31 0000918251 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0000918251 us-gaap:RetainedEarningsMember 2024-12-31 0000918251 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0000918251 us-gaap:CommonStockMember 2023-03-31 0000918251 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000918251 us-gaap:RetainedEarningsMember 2023-03-31 0000918251 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0000918251 2023-03-31 0000918251 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0000918251 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0000918251 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0000918251 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0000918251 2023-04-01 2023-06-30 0000918251 us-gaap:CommonStockMember 2023-06-30 0000918251 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0000918251 us-gaap:RetainedEarningsMember 2023-06-30 0000918251 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0000918251 2023-06-30 0000918251 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0000918251 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0000918251 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0000918251 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0000918251 2023-07-01 2023-09-30 0000918251 us-gaap:CommonStockMember 2023-09-30 0000918251 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0000918251 us-gaap:RetainedEarningsMember 2023-09-30 0000918251 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0000918251 2023-09-30 0000918251 us-gaap:CommonStockMember 2023-10-01 2023-12-31 0000918251 us-gaap:AdditionalPaidInCapitalMember 2023-10-01 2023-12-31 0000918251 us-gaap:RetainedEarningsMember 2023-10-01 2023-12-31 0000918251 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-10-01 2023-12-31 0000918251 us-gaap:CommonStockMember 2023-12-31 0000918251 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000918251 us-gaap:RetainedEarningsMember 2023-12-31 0000918251 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000918251 2023-12-31 0000918251 mpaa:CustomerAMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2024-10-01 2024-12-31 0000918251 mpaa:CustomerAMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2023-10-01 2023-12-31 0000918251 mpaa:CustomerAMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2024-12-31 0000918251 mpaa:CustomerAMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2023-12-31 0000918251 mpaa:CustomerCMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2024-10-01 2024-12-31 0000918251 mpaa:CustomerCMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2023-10-01 2023-12-31 0000918251 mpaa:CustomerCMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2024-12-31 0000918251 mpaa:CustomerCMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2023-12-31 0000918251 mpaa:CustomerBMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2024-10-01 2024-12-31 0000918251 mpaa:CustomerBMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2023-10-01 2023-12-31 0000918251 mpaa:CustomerBMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2024-12-31 0000918251 mpaa:CustomerBMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2023-12-31 0000918251 mpaa:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2024-12-31 0000918251 mpaa:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2024-03-31 0000918251 mpaa:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2024-12-31 0000918251 mpaa:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2024-03-31 0000918251 mpaa:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2024-12-31 0000918251 mpaa:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2024-03-31 0000918251 mpaa:RotatingElectricalProductsMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2024-10-01 2024-12-31 0000918251 mpaa:RotatingElectricalProductsMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2023-10-01 2023-12-31 0000918251 mpaa:RotatingElectricalProductsMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2024-04-01 2024-12-31 0000918251 mpaa:RotatingElectricalProductsMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2023-04-01 2023-12-31 0000918251 mpaa:BrakeRelatedProductsMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2024-10-01 2024-12-31 0000918251 mpaa:BrakeRelatedProductsMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2023-10-01 2023-12-31 0000918251 mpaa:BrakeRelatedProductsMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2024-04-01 2024-12-31 0000918251 mpaa:BrakeRelatedProductsMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2023-04-01 2023-12-31 0000918251 mpaa:WheelHubProductsMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2024-10-01 2024-12-31 0000918251 mpaa:WheelHubProductsMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2023-10-01 2023-12-31 0000918251 mpaa:WheelHubProductsMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2024-04-01 2024-12-31 0000918251 mpaa:WheelHubProductsMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2023-04-01 2023-12-31 0000918251 mpaa:OtherProductsMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2024-10-01 2024-12-31 0000918251 mpaa:OtherProductsMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2023-10-01 2023-12-31 0000918251 mpaa:OtherProductsMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2024-04-01 2024-12-31 0000918251 mpaa:OtherProductsMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2023-04-01 2023-12-31 0000918251 us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2024-10-01 2024-12-31 0000918251 us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2023-10-01 2023-12-31 0000918251 us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2024-04-01 2024-12-31 0000918251 us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2023-04-01 2023-12-31 0000918251 mpaa:ParentCompanyCreditAgreementMember 2024-12-31 0000918251 mpaa:ParentCompanyCreditAgreementMember us-gaap:RevolvingCreditFacilityMember 2024-12-31 0000918251 mpaa:ParentCompanyCreditAgreementMember us-gaap:LoansPayableMember 2024-12-31 0000918251 mpaa:ParentCompanyCreditAgreementMember 2024-04-01 2024-12-31 0000918251 mpaa:ParentCompanyCreditAgreementMember us-gaap:RevolvingCreditFacilityMember 2024-03-31 0000918251 us-gaap:LetterOfCreditMember us-gaap:RevolvingCreditFacilityMember 2024-12-31 0000918251 us-gaap:RevolvingCreditFacilityMember 2024-12-31 0000918251 us-gaap:RevolvingCreditFacilityMember 2024-03-31 0000918251 us-gaap:ConvertibleDebtMember 2023-03-31 0000918251 us-gaap:ConvertibleDebtMember 2024-04-01 2024-12-31 0000918251 us-gaap:ConvertibleDebtMember 2024-12-31 0000918251 us-gaap:ConvertibleDebtMember 2024-03-31 0000918251 us-gaap:ConvertibleDebtMember 2024-10-01 2024-12-31 0000918251 us-gaap:ConvertibleDebtMember 2023-10-01 2023-12-31 0000918251 us-gaap:ConvertibleDebtMember 2023-04-01 2023-12-31 0000918251 us-gaap:CommonStockMember 2024-10-01 2024-12-31 0000918251 us-gaap:CommonStockMember 2024-04-01 2024-12-31 0000918251 us-gaap:CommonStockMember 2023-10-01 2023-12-31 0000918251 us-gaap:CommonStockMember 2023-04-01 2023-12-31 0000918251 us-gaap:ConvertibleDebtSecuritiesMember 2024-10-01 2024-12-31 0000918251 us-gaap:ConvertibleDebtSecuritiesMember 2024-04-01 2024-12-31 0000918251 us-gaap:ConvertibleDebtSecuritiesMember 2023-10-01 2023-12-31 0000918251 us-gaap:ConvertibleDebtSecuritiesMember 2023-04-01 2023-12-31 0000918251 us-gaap:ForeignExchangeForwardMember 2024-12-31 0000918251 us-gaap:ForeignExchangeForwardMember 2024-03-31 0000918251 srt:MaximumMember us-gaap:ForeignExchangeForwardMember 2024-04-01 2024-12-31 0000918251 us-gaap:ForeignExchangeForwardMember mpaa:ForeignCurrencyTransactionGainLossMember 2024-10-01 2024-12-31 0000918251 us-gaap:ForeignExchangeForwardMember mpaa:ForeignCurrencyTransactionGainLossMember 2023-10-01 2023-12-31 0000918251 us-gaap:ForeignExchangeForwardMember mpaa:ForeignCurrencyTransactionGainLossMember 2024-04-01 2024-12-31 0000918251 us-gaap:ForeignExchangeForwardMember mpaa:ForeignCurrencyTransactionGainLossMember 2023-04-01 2023-12-31 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2024-12-31 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2024-03-31 0000918251 us-gaap:FairValueInputsLevel3Member us-gaap:ConvertibleNotesPayableMember 2024-12-31 0000918251 us-gaap:FairValueInputsLevel3Member us-gaap:ConvertibleNotesPayableMember 2024-03-31 0000918251 us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0000918251 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0000918251 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0000918251 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0000918251 us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0000918251 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0000918251 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0000918251 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-12-31 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-03-31 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember mpaa:MeasurementInputCostOfEquityMember 2024-12-31 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember mpaa:MeasurementInputCostOfEquityMember 2024-03-31 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember mpaa:MeasurementInputWeightedAverageCostOfCapitalMember 2024-12-31 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember mpaa:MeasurementInputWeightedAverageCostOfCapitalMember 2024-03-31 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:MeasurementInputPriceVolatilityMember 2024-12-31 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:MeasurementInputPriceVolatilityMember 2024-03-31 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:MeasurementInputEbitdaMultipleMember 2024-12-31 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:MeasurementInputEbitdaMultipleMember 2024-03-31 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2024-09-30 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2023-09-30 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2023-03-31 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2024-10-01 2024-12-31 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2023-10-01 2023-12-31 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2024-04-01 2024-12-31 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2023-04-01 2023-12-31 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2023-12-31 0000918251 us-gaap:EmployeeStockOptionMember 2024-04-01 2024-12-31 0000918251 us-gaap:EmployeeStockOptionMember 2023-12-31 0000918251 us-gaap:EmployeeStockOptionMember 2024-12-31 0000918251 us-gaap:RestrictedStockUnitsRSUMember 2024-04-01 2024-12-31 0000918251 us-gaap:RestrictedStockUnitsRSUMember 2023-04-01 2023-12-31 0000918251 us-gaap:RestrictedStockUnitsRSUMember 2024-12-31 0000918251 mpaa:PerformanceSharesGrantDate1Member us-gaap:PerformanceSharesMember 2024-04-01 2024-12-31 0000918251 us-gaap:PerformanceSharesMember 2024-04-01 2024-12-31 0000918251 srt:MinimumMember us-gaap:PerformanceSharesMember 2024-04-01 2024-12-31 0000918251 srt:MaximumMember us-gaap:PerformanceSharesMember 2024-04-01 2024-12-31 0000918251 us-gaap:PerformanceSharesMember 2023-04-01 2023-12-31 0000918251 us-gaap:PerformanceSharesMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2023-12-31 0000918251 us-gaap:PerformanceSharesMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2023-12-31 0000918251 us-gaap:PerformanceSharesMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2023-12-31 0000918251 us-gaap:PerformanceSharesMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2023-04-01 2023-12-31 0000918251 us-gaap:PerformanceSharesMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2023-04-01 2023-12-31 0000918251 us-gaap:PerformanceSharesMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2023-04-01 2023-12-31 0000918251 srt:MinimumMember us-gaap:PerformanceSharesMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2023-04-01 2023-12-31 0000918251 srt:MaximumMember us-gaap:PerformanceSharesMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2023-04-01 2023-12-31 0000918251 srt:MinimumMember us-gaap:PerformanceSharesMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2023-12-31 0000918251 srt:MaximumMember us-gaap:PerformanceSharesMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2023-12-31 0000918251 mpaa:PerformanceSharesGrantDate2Member us-gaap:PerformanceSharesMember 2024-04-01 2024-12-31 0000918251 us-gaap:PerformanceSharesMember 2024-12-31 0000918251 us-gaap:EmployeeStockOptionMember 2023-04-01 2023-12-31 0000918251 us-gaap:EmployeeStockOptionMember 2024-03-31 0000918251 us-gaap:RestrictedStockUnitsRSUMember 2024-03-31 0000918251 srt:MinimumMember us-gaap:PerformanceSharesMember 2023-04-01 2023-12-31 0000918251 srt:MaximumMember us-gaap:PerformanceSharesMember 2023-04-01 2023-12-31 0000918251 us-gaap:PerformanceSharesMember 2024-03-31 0000918251 mpaa:CustomerReturnsRGAIssuedMember 2024-12-31 0000918251 mpaa:CustomerReturnsRGAIssuedMember 2024-03-31 0000918251 mpaa:CustomerFinishedGoodsReturnsAccrualMember 2024-12-31 0000918251 mpaa:CustomerFinishedGoodsReturnsAccrualMember 2024-03-31 0000918251 mpaa:HardPartsSegmentMember 2024-10-01 2024-12-31 0000918251 us-gaap:AllOtherSegmentsMember 2024-10-01 2024-12-31 0000918251 us-gaap:IntersegmentEliminationMember mpaa:HardPartsSegmentMember 2024-10-01 2024-12-31 0000918251 us-gaap:IntersegmentEliminationMember us-gaap:AllOtherSegmentsMember 2024-10-01 2024-12-31 0000918251 us-gaap:IntersegmentEliminationMember 2024-10-01 2024-12-31 0000918251 us-gaap:OperatingSegmentsMember mpaa:HardPartsSegmentMember 2024-10-01 2024-12-31 0000918251 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2024-10-01 2024-12-31 0000918251 us-gaap:OperatingSegmentsMember 2024-10-01 2024-12-31 0000918251 us-gaap:OperatingSegmentsMember mpaa:HardPartsSegmentMember 2024-12-31 0000918251 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2024-12-31 0000918251 us-gaap:OperatingSegmentsMember 2024-12-31 0000918251 mpaa:HardPartsSegmentMember 2023-10-01 2023-12-31 0000918251 us-gaap:AllOtherSegmentsMember 2023-10-01 2023-12-31 0000918251 us-gaap:IntersegmentEliminationMember mpaa:HardPartsSegmentMember 2023-10-01 2023-12-31 0000918251 us-gaap:IntersegmentEliminationMember us-gaap:AllOtherSegmentsMember 2023-10-01 2023-12-31 0000918251 us-gaap:IntersegmentEliminationMember 2023-10-01 2023-12-31 0000918251 us-gaap:OperatingSegmentsMember mpaa:HardPartsSegmentMember 2023-10-01 2023-12-31 0000918251 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2023-10-01 2023-12-31 0000918251 us-gaap:OperatingSegmentsMember 2023-10-01 2023-12-31 0000918251 us-gaap:OperatingSegmentsMember mpaa:HardPartsSegmentMember 2023-12-31 0000918251 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2023-12-31 0000918251 us-gaap:OperatingSegmentsMember 2023-12-31 0000918251 mpaa:HardPartsSegmentMember 2024-04-01 2024-12-31 0000918251 us-gaap:AllOtherSegmentsMember 2024-04-01 2024-12-31 0000918251 us-gaap:IntersegmentEliminationMember mpaa:HardPartsSegmentMember 2024-04-01 2024-12-31 0000918251 us-gaap:IntersegmentEliminationMember us-gaap:AllOtherSegmentsMember 2024-04-01 2024-12-31 0000918251 us-gaap:IntersegmentEliminationMember 2024-04-01 2024-12-31 0000918251 us-gaap:OperatingSegmentsMember mpaa:HardPartsSegmentMember 2024-04-01 2024-12-31 0000918251 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2024-04-01 2024-12-31 0000918251 us-gaap:OperatingSegmentsMember 2024-04-01 2024-12-31 0000918251 mpaa:HardPartsSegmentMember 2023-04-01 2023-12-31 0000918251 us-gaap:AllOtherSegmentsMember 2023-04-01 2023-12-31 0000918251 us-gaap:IntersegmentEliminationMember mpaa:HardPartsSegmentMember 2023-04-01 2023-12-31 0000918251 us-gaap:IntersegmentEliminationMember us-gaap:AllOtherSegmentsMember 2023-04-01 2023-12-31 0000918251 us-gaap:IntersegmentEliminationMember 2023-04-01 2023-12-31 0000918251 us-gaap:OperatingSegmentsMember mpaa:HardPartsSegmentMember 2023-04-01 2023-12-31 0000918251 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2023-04-01 2023-12-31 0000918251 us-gaap:OperatingSegmentsMember 2023-04-01 2023-12-31 0000918251 us-gaap:OperatingSegmentsMember mpaa:HardPartsSegmentMember 2024-03-31 0000918251 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2024-03-31 0000918251 us-gaap:IntersegmentEliminationMember 2024-12-31 0000918251 us-gaap:IntersegmentEliminationMember 2024-03-31 0000918251 us-gaap:CommonStockMember 2018-08-31 0000918251 us-gaap:CommonStockMember 2024-04-01 2024-12-31 0000918251 us-gaap:CommonStockMember 2023-04-01 2023-12-31 0000918251 us-gaap:ManufacturingFacilityMember mpaa:CompanyCoOwnedByMemberOfManagementMember 2022-12-31 0000918251 us-gaap:ManufacturingFacilityMember mpaa:CompanyCoOwnedByMemberOfManagementMember 2024-12-31 0000918251 us-gaap:ManufacturingFacilityMember mpaa:CompanyCoOwnedByMemberOfManagementMember 2024-04-01 2024-12-31 0000918251 us-gaap:ManufacturingFacilityMember mpaa:CompanyCoOwnedByMemberOfManagementMember us-gaap:SubsequentEventMember 2025-02-01 2025-02-28 0000918251 us-gaap:ManufacturingFacilityMember mpaa:CompanyCoOwnedByMemberOfManagementMember us-gaap:SubsequentEventMember 2025-02-28 0000918251 us-gaap:ManufacturingFacilityMember mpaa:CompanyCoOwnedByMemberOfManagementMember 2024-10-01 2024-12-31 0000918251 us-gaap:ManufacturingFacilityMember mpaa:CompanyCoOwnedByMemberOfManagementMember 2023-10-01 2023-12-31 0000918251 us-gaap:ManufacturingFacilityMember mpaa:CompanyCoOwnedByMemberOfManagementMember 2023-04-01 2023-12-31 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure mpaa:Segment utr:sqft

http://fasb.org/us-gaap/2025#RelatedPartyMember http://fasb.org/us-gaap/2025#RelatedPartyMember http://fasb.org/us-gaap/2025#OperatingLeaseRightOfUseAsset http://fasb.org/us-gaap/2025#OperatingLeaseRightOfUseAsset http://fasb.org/us-gaap/2025#PropertyPlantAndEquipmentNet http://fasb.org/us-gaap/2025#PropertyPlantAndEquipmentNet http://fasb.org/us-gaap/2025#OperatingLeaseLiabilityCurrent http://fasb.org/us-gaap/2025#OperatingLeaseLiabilityCurrent http://fasb.org/us-gaap/2025#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2025#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2025#OperatingLeaseLiabilityNoncurrent http://fasb.org/us-gaap/2025#OperatingLeaseLiabilityNoncurrent http://fasb.org/us-gaap/2025#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2025#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2025#AccountsPayableAndAccruedLiabilitiesCurrent 0.0033 0.0033 0.0033 0000918251 false 2026 Q1 --03-31 0000918251 2025-04-01 2025-06-30 0000918251 2025-08-04 0000918251 2025-06-30 0000918251 2025-03-31 0000918251 us-gaap:SeriesAPreferredStockMember 2025-06-30 0000918251 us-gaap:SeriesAPreferredStockMember 2025-03-31 0000918251 2024-04-01 2024-06-30 0000918251 us-gaap:CommonStockMember 2025-03-31 0000918251 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0000918251 us-gaap:RetainedEarningsMember 2025-03-31 0000918251 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0000918251 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0000918251 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0000918251 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0000918251 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-04-01 2025-06-30 0000918251 us-gaap:CommonStockMember 2025-06-30 0000918251 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0000918251 us-gaap:RetainedEarningsMember 2025-06-30 0000918251 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-06-30 0000918251 us-gaap:CommonStockMember 2024-03-31 0000918251 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000918251 us-gaap:RetainedEarningsMember 2024-03-31 0000918251 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0000918251 2024-03-31 0000918251 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0000918251 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0000918251 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0000918251 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0000918251 us-gaap:CommonStockMember 2024-06-30 0000918251 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0000918251 us-gaap:RetainedEarningsMember 2024-06-30 0000918251 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0000918251 2024-06-30 0000918251 mpaa:CustomerAMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2025-04-01 2025-06-30 0000918251 mpaa:CustomerAMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2024-06-30 0000918251 mpaa:CustomerBMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2025-04-01 2025-06-30 0000918251 mpaa:CustomerBMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2024-06-30 0000918251 mpaa:CustomerCMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2025-04-01 2025-06-30 0000918251 mpaa:CustomerCMember us-gaap:SalesRevenueProductLineMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2024-06-30 0000918251 mpaa:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-04-01 2025-06-30 0000918251 mpaa:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2025-03-31 0000918251 mpaa:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-04-01 2025-06-30 0000918251 mpaa:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2025-03-31 0000918251 mpaa:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-04-01 2025-06-30 0000918251 mpaa:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2025-03-31 0000918251 mpaa:RotatingElectricalProductsMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2025-04-01 2025-06-30 0000918251 mpaa:RotatingElectricalProductsMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2024-04-01 2025-03-31 0000918251 mpaa:BrakeRelatedProductsMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2025-04-01 2025-06-30 0000918251 mpaa:BrakeRelatedProductsMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2024-04-01 2025-03-31 0000918251 mpaa:WheelHubProductsMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2025-04-01 2025-06-30 0000918251 mpaa:WheelHubProductsMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2024-04-01 2025-03-31 0000918251 mpaa:OtherProductsMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2025-04-01 2025-06-30 0000918251 mpaa:OtherProductsMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2024-04-01 2025-03-31 0000918251 us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2025-04-01 2025-06-30 0000918251 us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2024-04-01 2025-03-31 0000918251 mpaa:ParentCompanyCreditAgreementMember 2025-06-30 0000918251 mpaa:ParentCompanyCreditAgreementMember us-gaap:RevolvingCreditFacilityMember 2025-06-30 0000918251 mpaa:ParentCompanyCreditAgreementMember us-gaap:LoansPayableMember 2025-06-30 0000918251 mpaa:ParentCompanyCreditAgreementMember 2025-04-01 2025-06-30 0000918251 mpaa:ParentCompanyCreditAgreementMember us-gaap:RevolvingCreditFacilityMember 2025-03-31 0000918251 us-gaap:LetterOfCreditMember us-gaap:RevolvingCreditFacilityMember 2025-06-30 0000918251 us-gaap:RevolvingCreditFacilityMember 2025-06-30 0000918251 us-gaap:RevolvingCreditFacilityMember 2025-03-31 0000918251 us-gaap:ConvertibleDebtMember 2023-03-31 0000918251 us-gaap:ConvertibleDebtMember 2025-04-01 2025-06-30 0000918251 us-gaap:ConvertibleDebtMember 2025-06-30 0000918251 us-gaap:ConvertibleDebtMember 2025-03-31 0000918251 us-gaap:ConvertibleDebtMember 2024-04-01 2024-06-30 0000918251 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0000918251 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0000918251 us-gaap:ConvertibleDebtSecuritiesMember 2025-04-01 2025-06-30 0000918251 us-gaap:ConvertibleDebtSecuritiesMember 2024-04-01 2024-06-30 0000918251 us-gaap:ForeignExchangeForwardMember 2025-06-30 0000918251 us-gaap:ForeignExchangeForwardMember 2025-03-31 0000918251 srt:MaximumMember us-gaap:ForeignExchangeForwardMember 2025-04-01 2025-06-30 0000918251 us-gaap:ForeignExchangeForwardMember mpaa:ForeignCurrencyTransactionGainLossMember 2025-04-01 2025-06-30 0000918251 us-gaap:ForeignExchangeForwardMember mpaa:ForeignCurrencyTransactionGainLossMember 2024-04-01 2024-06-30 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2025-06-30 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2025-03-31 0000918251 us-gaap:FairValueInputsLevel3Member us-gaap:ConvertibleNotesPayableMember 2025-06-30 0000918251 us-gaap:FairValueInputsLevel3Member us-gaap:ConvertibleNotesPayableMember 2025-03-31 0000918251 us-gaap:FairValueMeasurementsRecurringMember 2025-06-30 0000918251 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-06-30 0000918251 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-06-30 0000918251 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-06-30 0000918251 us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000918251 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000918251 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000918251 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2025-06-30 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2025-03-31 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember mpaa:MeasurementInputCostOfEquityMember 2025-06-30 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember mpaa:MeasurementInputCostOfEquityMember 2025-03-31 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember mpaa:MeasurementInputWeightedAverageCostOfCapitalMember 2025-06-30 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember mpaa:MeasurementInputWeightedAverageCostOfCapitalMember 2025-03-31 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:MeasurementInputPriceVolatilityMember 2025-06-30 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:MeasurementInputPriceVolatilityMember 2025-03-31 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:MeasurementInputEbitdaMultipleMember 2025-06-30 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:MeasurementInputEbitdaMultipleMember 2025-03-31 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2024-03-31 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2025-04-01 2025-06-30 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2024-04-01 2024-06-30 0000918251 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2024-06-30 0000918251 us-gaap:EmployeeStockOptionMember 2025-04-01 2025-06-30 0000918251 us-gaap:EmployeeStockOptionMember 2024-04-01 2024-06-30 0000918251 us-gaap:EmployeeStockOptionMember 2025-06-30 0000918251 us-gaap:RestrictedStockUnitsRSUMember 2025-04-01 2025-06-30 0000918251 us-gaap:RestrictedStockUnitsRSUMember 2024-04-01 2024-06-30 0000918251 us-gaap:RestrictedStockUnitsRSUMember 2025-06-30 0000918251 us-gaap:PerformanceSharesMember 2025-04-01 2025-06-30 0000918251 us-gaap:PerformanceSharesMember 2024-04-01 2024-06-30 0000918251 mpaa:PerformanceShareUnitsStockPriceMember 2025-04-01 2025-06-30 0000918251 mpaa:PerformanceShareUnitsStockPriceMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2025-06-30 0000918251 mpaa:PerformanceShareUnitsStockPriceMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2025-04-01 2025-06-30 0000918251 mpaa:PerformanceShareUnitsStockPriceMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2025-06-30 0000918251 mpaa:PerformanceShareUnitsStockPriceMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2025-04-01 2025-06-30 0000918251 mpaa:PerformanceShareUnitsStockPriceMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2025-06-30 0000918251 mpaa:PerformanceShareUnitsStockPriceMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2025-04-01 2025-06-30 0000918251 srt:MinimumMember mpaa:PerformanceShareUnitsStockPriceMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2025-04-01 2025-06-30 0000918251 srt:MaximumMember mpaa:PerformanceShareUnitsStockPriceMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2025-04-01 2025-06-30 0000918251 srt:MinimumMember mpaa:PerformanceShareUnitsStockPriceMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2025-06-30 0000918251 srt:MaximumMember mpaa:PerformanceShareUnitsStockPriceMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2025-06-30 0000918251 mpaa:PerformanceShareUnitsStockPriceMember 2024-04-01 2024-06-30 0000918251 mpaa:PerformanceShareUnitsTotalShareholderReturnMember 2025-04-01 2025-06-30 0000918251 mpaa:PerformanceShareUnitsTotalShareholderReturnMember 2024-04-01 2024-06-30 0000918251 srt:MinimumMember mpaa:PerformanceShareUnitsTotalShareholderReturnMember 2025-04-01 2025-06-30 0000918251 srt:MaximumMember mpaa:PerformanceShareUnitsTotalShareholderReturnMember 2025-04-01 2025-06-30 0000918251 us-gaap:PerformanceSharesMember 2025-06-30 0000918251 us-gaap:EmployeeStockOptionMember 2025-03-31 0000918251 us-gaap:RestrictedStockUnitsRSUMember 2025-03-31 0000918251 srt:MinimumMember us-gaap:PerformanceSharesMember 2025-04-01 2025-06-30 0000918251 srt:MaximumMember us-gaap:PerformanceSharesMember 2025-04-01 2025-06-30 0000918251 us-gaap:PerformanceSharesMember 2025-03-31 0000918251 mpaa:AccountsReceivableNetCurrentMember 2025-06-30 0000918251 mpaa:AccountsReceivableNetCurrentMember 2025-03-31 0000918251 mpaa:CustomerFinishedGoodsReturnsAccrualMember 2025-06-30 0000918251 mpaa:CustomerFinishedGoodsReturnsAccrualMember 2025-03-31 0000918251 us-gaap:OperatingSegmentsMember mpaa:ExternalCustomersMember us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember 2025-04-01 2025-06-30 0000918251 us-gaap:OperatingSegmentsMember mpaa:ExternalCustomersMember us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember 2024-04-01 2024-06-30 0000918251 us-gaap:IntersegmentEliminationMember us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember 2025-04-01 2025-06-30 0000918251 us-gaap:IntersegmentEliminationMember us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember 2024-04-01 2024-06-30 0000918251 us-gaap:OperatingSegmentsMember us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember 2025-04-01 2025-06-30 0000918251 us-gaap:OperatingSegmentsMember us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember 2024-04-01 2024-06-30 0000918251 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2025-04-01 2025-06-30 0000918251 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2024-04-01 2024-06-30 0000918251 us-gaap:IntersegmentEliminationMember 2025-04-01 2025-06-30 0000918251 us-gaap:IntersegmentEliminationMember 2024-04-01 2024-06-30 0000918251 us-gaap:OperatingSegmentsMember 2025-04-01 2025-06-30 0000918251 us-gaap:OperatingSegmentsMember 2024-04-01 2024-06-30 0000918251 us-gaap:OperatingSegmentsMember us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember 2025-06-30 0000918251 us-gaap:OperatingSegmentsMember us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember 2025-03-31 0000918251 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2025-06-30 0000918251 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2025-03-31 0000918251 us-gaap:IntersegmentEliminationMember 2025-06-30 0000918251 us-gaap:IntersegmentEliminationMember 2025-03-31 0000918251 us-gaap:CommonStockMember 2018-08-31 0000918251 us-gaap:ManufacturingFacilityMember mpaa:CompanyCoOwnedByMemberOfManagementMember 2025-06-30 0000918251 us-gaap:ManufacturingFacilityMember mpaa:CompanyCoOwnedByMemberOfManagementMember 2025-04-01 2025-06-30 0000918251 us-gaap:ManufacturingFacilityMember mpaa:CompanyCoOwnedByMemberOfManagementMember 2024-04-01 2024-06-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure mpaa:Segment utr:sqft

Filing Compare · MOTORCAR PARTS OF AMERICA INC